Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Dr. Richard Scolyer
Based on 254 articles published since 2007
||||
Expertise Level
The expertise of Dr. Richard Scolyer ranks in the
  • Top 0.011%
  • ... of 100,393 published authors worldwide on Melanoma
  • ... from 2007 through 2018
  • ... based on contributions to 254 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Scolyer, R A   ·   Scolyer, Richard A   ·   Scolyer, Richard   ·   Scolyer, R
Work Locations
Details
Confirmed:
(May 2014) 
  Royal Prince Alfred Hospital      
2017
  • Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX. · Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia. · Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL. · Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia. · Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA. · Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA. · Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia. · Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX. · Director General, Gustave Roussy Cancer Institute, Villejuif, France. · Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA. · Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 29028110
  • Translational Research Institute, Henan Provincial People's Hospital, Henan, China. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, New South Wales, Australia. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · School of Environmental and Life Sciences, The University of Newcastle, New South Wales, Australia. · Translational Research Institute, Henan Provincial People's Hospital, Henan, China. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. · Pubmed 28947420
  • Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · Institute of Molecular Medicine, University Hospital Bonn, University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, Magdeburg, Germany. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Developmental Pathology, Institute of Pathology, University of Bonn Medical School, Bonn, Germany. · Molecular Immunology and Cell Biology, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany. · Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · University of California Los Angeles (UCLA), Los Angeles, California. · Jonsson Comprehensive Cancer Center, Los Angeles, California. · Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. · Pubmed 28652246
  • Melanoma Institute Australia, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. · Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 28573666
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Plastic Surgery, Westmead Hospital, Sydney, NSW, Australia. · Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 28547563
  • Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. · Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia. · Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain. · Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Hospital at Westmead, The University of Sydney, Westmead, New South Wales Sydney, 2145, Australia. · Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia. · University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Melbourne, Victoria 3052, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales 2006, Australia. · Olivia Newton-John Cancer Research Institute, La Trobe University, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia. · Macquarie University, North Ryde, Sydney, New South Wales 2109, Australia. · Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales 2065, Australia. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria 3000, Australia. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, Australia. · Pubmed 28467829
  • Department of Dermatology, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile. · Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 28467525
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney. · Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney. · Melanoma Institute Australia, Sydney. · Sydney Medical School, The University of Sydney, Sydney. · Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 28327969
  • Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, University of Sydney, Westmead, NSW, Australia. · Pubmed 28067894
  • Program in Dermatopathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Melanoma Institute Australia, North Sydney, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Discipline of Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28032662
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia. · Pubmed 28024115
  • School of Mathematics and Statistics, The University of Sydney, Sydney, Australia. · Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA. · Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA. · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, Australia. · ARC Centre of Excellence for Mathematical & Statistical Frontiers. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Discipline Pathology, Sydney Medical School, The University of Sydney, Sydney, Australia. · Pubmed 27833072
  • Department of Biology, Shepherd University, Shepherdstown, WV, USA. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Robert C. Byrd Health Sciences Center, West Virginia University Cancer Institute, West Virginia University, Morgantown, WV, USA. · Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA. · Department of Pathology, Midwestern University, Downers Grove, IL, USA. · Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. · Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 27775691
  • The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: · Pubmed 27720652
  • Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. Electronic address: · Pubmed 28689094
2016
  • Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: · School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, Australia; Hunter Cancer Research Alliance (HCRA), Calvary Mater Newcastle, Waratah, Australia; Division of Anatomical Pathology, Pathology North (Hunter), New Lambton Heights, NSW, Australia. · Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Pubmed 27020382
  • Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. · Arizona State University, Phoenix, AZ, USA. · School of Medicine, Mayo Clinic, Rochester, MN, USA. · Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University, Durham, NC, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Melanoma Institute Australia, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. · Pubmed 27052645
  • Melanoma Institute Australia, North Sydney, Australia; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, North Sydney, Australia; The University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. Electronic address: · Pubmed 27020392
  • School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, Australia. · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. Electronic address: · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 26763444
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25956574
  • Department of Pathology, McGill University, Montreal, Quebec, Canada. · Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Melanoma Institute Australia, Royal Prince Alfred Hospital, and University of Sydney, Sydney, New South Wales, Australia. · Department of Immunology, Genetics and Pathology, and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France. · Centre for Research in Epidemiology and Population Health (CESP), INSERM, UMR 1018, Université Paris-Sud, Kremlin-Bicetre, France. · Centre de Recherche sur l'Inflammation, INSERM, UMR S 1149, Labex Inflamex, Université Paris-Diderot Sorbonne Paris-Cité, Paris, France. · CNRS, UMR 8200, Université Paris-Sud, Villejuif, France. · CNRS UMR 8200, Universite Paris-Sud, Gustave Roussy, Villejuif, France. · Hématopoïèse normale et pathologique, INSERM UMR 1170, Université Paris-Sud, Gustave Roussy, Villejuif, France. · Laboratory of Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium. · Laboratory of Computational Biology, VIB Center for the Biology of Disease, KU Leuven, Leuven, Belgium. · Department of Human Genetics, KU Leuven, Leuven, Belgium. · Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada. · Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, McGill University, Montreal, Quebec, Canada. · Pubmed 27974665
  • Department of Pathology and Dermatology, Moffitt Cancer Center/University of South Florida, Tampa, FL, United States. Electronic address: · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Dermatology Department, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Pubmed 27956274
  • Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Electronic address: · Protea Biosciences Inc, Morgantown, West Virginia. · Dermatopathologie Friedreichshafen, Friedrechshafen, Germany. · Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Department of Dermatology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York. · Department of Dermatology, Medical University of Graz, Graz, Austria. · Department of Dermatology, Medical University of Graz, Graz, Austria; Kempf und Pfaltz Histologische Diagnostik, Zürich, Switzerland. · Rabkin Dermatopathology Laboratory, Tarentum, Pennsylvania. · Department of Dermatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio; Cleveland Skin Pathology Laboratory Inc, Beachwood, Ohio. · Department of Pathology, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Emory University School of Medicine, Atlanta, Georgia; Children's Healthcare of Atlanta, Atlanta, Georgia. · Department of Surgery, Emory University School of Medicine, Atlanta, Georgia. · Universidad Complutense de Madrid Facultad de Medicina, Madrid, Spain. · Miraca Life Sciences, Newton, Massachusetts; Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts. · Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts. · Dermatopathologie Praticien Hospitalier, Département de Pathologie, Hôpital Necker-Enfants Malades, Paris, France. · Viollier Morges SA Lausanne, Lausanne, Switzerland. · DermDX New England, Boston, Massachusetts; Beacon Pathology, Dover, Massachusetts. · Department of Pathology, Hospital Obrero Nro 1, La Paz, Bolivia. · Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Pathology, University of Chile, Santiago, Chile. · Department of Dermatology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York; Muhlbauer Dermatopathology Laboratory, Pittsford, New York. · Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. · Department of Dermatology, Universidad Peruana Cayetano Heredia, Lima, Peru. · Department of Dermatology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut. · Mass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 27502312
  • Sydney Melanoma Diagnostic Centre and Dermatology Department, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Discipline of Dermatology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, 40 Rocklands Road, North Sydney, NSW, Australia. · Dermatology Unit, Second University of Naples, Naples, Italy. · Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova, University of Modena and Reggio Emilia, Modena, Italy. · Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. · Sydney School of Public Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Pubmed 27177158
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Medical Genomics, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Oncology, Royal North Shore and Mater Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 27151331
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 27075324
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia. Electronic address: · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 27020503
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, Australia; Hunter Cancer Research Alliance (HCRA), Calvary Mater Newcastle, Waratah, Australia; Division of Anatomical Pathology, Pathology North (Hunter), New Lambton Heights, Australia. Electronic address: · Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 27020383
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. · School of Mathematics and Statistics, The University of Sydney Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 26960397
  • Laboratory of Translational Cell and Tissue Research, University of Leuven, KUL, Leuven, Belgium. · Università Degli Studi di Milano-Bicocca, Milan, Italy. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Ludwig Institute for Cancer Research and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium. · Department of Surgical Oncology, UZ Gasthuisberg and KU Leuven, Leuven, Belgium. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26867783
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · The Strathfield Breast Centre, Strathfield, NSW, Australia. · Department of Breast and Endocrine Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia. · Department of Breast Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Surgery, Prince of Wales Hospital, Randwick, NSW, Australia. · Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. · Anatomical Pathology Department, Concord Repatriation General Hospital, Concord, NSW, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, Australia. · Pubmed 26588661
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Plastic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26561405
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Australia; Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. Electronic address: · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Australia; Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 27580960
2015
  • Melanoma Institute Australia, Sydney, Australia. · Department of Radiation Oncology, St Vincent's General Hospital, Sydney, Australia. · Genesis Cancer Care, Department of Radiation Oncology, Mater Hospital, Sydney, Australia. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Oslo University Hospital HF, The Norwegian Radium Hospital, Oslo, Norway. · Oslo University Hospital HF, The Norwegian Radium Hospital, Oslo, Norway. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Centre for Medical Psychology & Evidence-based Decision-making, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Psycho-Oncology Co-Operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · The Royal Melbourne Hospital & University of Melbourne, Parkville, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Centre for Medical Psychology & Evidence-based Decision-making, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Psycho-Oncology Co-Operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, Australia. · Concord Repatriation and General Hospital, Concord, Australia. · School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia. · Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Peter MacCallum Cancer Centre East Melbourne & University of Melbourne, Parkville, Australia. · Melanoma Institute Australia, Sydney, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Pubmed 25952979
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • School of Medicine and Public Health, The University of Newcastle, NSW 2308, Australia. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW 2308, Australia. · Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi 030013, China. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW 2006, Australia. · Children's Cancer Institute Australia for Medical Research, The University of New South Wales, Sydney, NSW 2052, Australia. · Pubmed 26573229
  • Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · National Human Genome Research Institute, US National Institutes of Health, Bethesda, Maryland, USA. · National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA. · Institute of Biochemistry, Food Science and Nutrition, Hebrew University, Rehovot, Israel. · Department of Biological Services, Weizmann Institute of Science, Rehovot, Israel. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. · Centre for Cancer Research, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 26502337
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Merck Research Laboratories, Palo Alto, CA, USA. · Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, NSW, Australia. · Pubmed 26403784
  • Department of Pathology, University of California, San Francisco, San Francisco, California, USA. · Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. · Five3 Genomics, LLC, Santa Cruz, California, USA. · Samsung Advanced Institute of Technology, Seoul, Korea. · Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA. · Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA. · Samsung Electronics Headquarters, Seoul, Korea. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Pubmed 26343386
  • NantOmics LLC, Santa Cruz, CA 95060; · Samsung Advanced Institute of Technology, Suwon-si, Gyeonggi-do, 443-803, Korea; · Department of Statistics, University of California, Berkeley, CA 94720-3860; · Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; · Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97239-30; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW 2050, Australia; · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Hematology and Oncology, University of California, San Francisco, CA 94143-1770; · Samsung Electronics, Inc. Seocho-gu, Seoul 137-857, Korea; · Department of Dermatology, University of California, San Francisco, CA 94115; · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Pathology, University of California, San Francisco, CA 94143-0511 · Pubmed 26286987
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Departments of Melanoma and Surgical Oncology, Camperdown, New South Wales, Australia [3] Mater Hospital, North Sydney, Sydney, New South Wales, Australia [4] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Kolling Institute, Royal North Shore Hospital, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25836739
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Poche Centre, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25827527
  • Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Howard Hughes Medical Institute NU Bioscientist Program, Weinberg College of Arts and Sciences, Northwestern University, Evanston, Illinois. · Department of Pathology, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Pubmed 25767211
  • School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. School of Life Science, Anhui Medical University, Anhui, China. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Shanxi, China. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. · Pubmed 25724678
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, New South Wales, Australia. Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · The Kinghorn Cancer Centre, Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25370473
  • Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA. · Sequencing Center, John Wayne Cancer Institute, Santa Monica, California, USA. · Melanoma Institute Australia and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Tissue Pathology and Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Department of Cell Research and Immunology, Tel-Aviv University, Tel-Aviv, Israel. · Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA; Sequencing Center, John Wayne Cancer Institute, Santa Monica, California, USA. Electronic address: · Pubmed 25243790
  • Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital, Sydney, Australia. · Westmead Hospital, Sydney, Australia. · Queensland Centre for Medical Genomics; Institute of Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Australia. · Canberra Hospital and Australian National University Medical School, Canberra, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital; Melanoma Institute Australia, Sydney, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow; Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom. · Melanoma Institute Australia; The University of Sydney and Westmead Institute for Cancer Research, Sydney, Australia · Pubmed 24821886
  • Melanoma Institute Australia, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 26072686
2014
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
  • School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW, Australia. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW, Australia. Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW, Australia. Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Taiyuan, Shanxi, China. · School of Medicine and Public Health, The University of Newcastle, NSW, Australia. · Pubmed 25365078
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America; The Group Health Research Institute, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia. · Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 24733413
  • School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · School of Mathematics and Statistics and Prince of Wales Clinical School, University of New South Wales, Kensington, NSW, 2052, Australia. · Discipline of Infectious Diseases and Immunology Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia. · Discipline of Dermatology, Bosch Institute, Faculty of Medicine, Sydney Medical School, Sydney, NSW, 2006, Australia. · Melanoma Institute Australia, North Sydney, NSW, 2060, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Westmead Institute of Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, 2145, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Pubmed 24435119
  • 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA. · 1] Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Westmead Institute for Cancer Research, NSW, Sydney, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Mater Hospital, Sydney, NSW, Australia [4] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA [3] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [4] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24434899
  • Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven (KU Leuven), Leuven, Belgium. · Surgical Oncology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Dermatology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium. · Embryo and Stem Cells, Department of Development and Regeneration, University of Leuven (KU Leuven), Leuven, Belgium. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Discipline of Surgery, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia. · Pubmed 24390218
  • 1] Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, University of Massachusetts Medical Center, Worcester, MA, USA. · Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Royal Prince Alfred Hospital, Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, Australia. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Divison of Endocrinology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 24390216
  • School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia. · Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Taiyuan, China. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24121273
  • Department of Dermatology, University of Duisburg-Essen, Essen, Germany. · Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · 1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23887304
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
  • Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Missenden Road, Sydney, NSW 2050, Australia. · Pubmed 24366302
2012
  • Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; The Melanoma Institute Australia, New South Wales, Australia. Electronic address: · Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia. · Department of Dermatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy. · Department of Pathology, University of Modena and Reggio Emilia, Reggio Emilia, Italy. · The Melanoma Institute Australia, New South Wales, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, Australia. · Department of Dermatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy; Department of Dermatology, University of Modena and Reggio Emilia, Reggio Emilia, Italy. · Pubmed 22718115
2011
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, NSW 2050, Australia. · Pubmed 21111957
2008
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 18697713
  • Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 18639451
2017
  • Lauren E. Haydu, Richard A. Scolyer, Serigne Lo, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, and John F. Thompson: The University of Sydney, Sydney; Richard A. Scolyer, Robyn P.M. Saw, and John F. Thompson, Royal Prince Alfred Hospital, Camperdown; Michael J. Quinn, The University of Wollongong, Wollongong, NSW, Australia; and Lauren E. Haydu, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28375785
2016
  • Departments of *Pathology ¶Surgery #Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY †Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ‡Melanoma Institute of Australia, North Sydney §Sydney Medical School, The University of Sydney, Sydney, NSW, Australia ∥Dartmouth College, Hanover, NH. · Pubmed 26872010
2015
  • 1Melanoma Institute Australia, North Sydney, NSW 2Sydney Medical School, The University of Sydney, Camperdown, NSW 3Immunogenomics Laboratory, Australian National University, Canberra, ACT 4Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Qld 5Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW 6Bioplatforms Australia, Macquarie University, North Ryde, NSW 7Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic 8The Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Vic 9Departments of Melanoma and Surgical Oncology 10Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; these authors contributed equally. · Pubmed 26517638
  • aDepartment of Dermatology, Westmead Hospital, Westmead bSydney Medical School, The University of Sydney cDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital dMelanoma Institute Australia eDepartment of Tissue Pathology and Diagnostic Oncology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, New South Wales, Sydney, Australia. · Pubmed 25380183
  • *Melanoma Institute Australia North Sydney †Sydney Medical School The University of Sydney ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital Sydney, NSW, Australia. · Pubmed 25871468
2014
  • aPeter Macallum Cancer Institute, East Melbourne bVictorian Melanoma Service, Alfred Hospital, Prahran cDepartment of Paediatrics, Murdoch Children's Research Institute, Royal Children's Hospital, The University of Melbourne, Parkville dThe Royal Children's Hospital, Flemington Road, Parkville, Victoria eMelanoma Institute Australia , Royal Prince Alfred Hospital, The University of Sydney, Sydney, New South Wales, Australia fDepartment of Medicine, Melanoma and Skin Cancer Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA. · Pubmed 24892957
  • Affiliations of authors: Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany (KGG, DS); Royal Prince Alfred Hospital, Camperdown, NSW, Australia (RAS); University of Sydney, Camperdown, NSW, Australia (RAS, JFT); Melanoma Institute Australia, North Sydney, NSW, Australia (RAS, JFT); Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA (KTF); Department of Pathology, and Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY (RM). · Pubmed 24511108
  • *Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands †Melanoma Institute Australia, Sydney, New South Wales, Australia Disciplines of ‡Surgery, and §Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; and ¶Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25072430
  • Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California (D.M.M., J.L.H., D.S.B.H.); Department of Tissue Oncology and Diagnostic Pathology (R.A.S., M.E.B., J.F.T.) and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia (J.F.T.); Sydney Medical School, The University of Sydney, Sydney, Australia (R.A.S., J.S.W., M.E.B., J.F.T.); Melanoma Institute Australia, Sydney, Australia (R.A.S., J.S.W.); Cellular and Molecular Biology Laboratory, Institute of Histology and Embryology, Mendoza, Argentina (M.R.); Tumor Biology Laboratory, Institute of Medicine and Experimental Biology of Cuyo, Mendoza, Argentina (L.M.V.-R.); Department of Pathology (R.M.), Center for Molecular Oncology (R.M.), and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York (R.M.); Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California (D.L.M.); Brain Tumor Center, Saint John's Health Center, Santa Monica, California (G.B., D.F.K.). · Pubmed 24968695
  • *Department of Dermatology †Robert H. Lurie Cancer Center †††Department of Preventive Medicine and the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL ‡Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY §Department of Pathology and Laboratory Medicine, Dermatopathology, UCLA Medical Center, Los Angeles ‡‡Departments of Pathology and Dermatology, University of California, San Francisco, San Francisco, CA ¶Pathology Service, Massachusetts General Hospital, Boston, MA #Department of Pathology, University of Pennsylvania, Philadelphia ¶¶Rabkin Dermatopathology Laboratory, P.C., Tarentum, PA Departments of **Pathology ††Dermatology, University of Michigan Medical Center, Ann Arbor, MI §§Department of Pathology, Section of Dermatopathology ∥∥Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX ∥Department of Histopathology, Royal Surrey County Hospital & Division of Clinical Medicine, University of Surrey, Guildford, Surrey, UK ##Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Melanoma Institute Australia and The University of Sydney, NSW, Australia ***Departments of Dermatology, Chonnam National University Medical School, Gwangju, Korea. · Pubmed 24618612
  • 1The University of Sydney, Sydney 2Melanoma Institute Australia, North Sydney 3Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia 4Canterbury Health Laboratories, Christchurch, New Zealand 5Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst 6Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 24614711
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
  • 1The Division of Dermatology, Department of Medicine, 2Division of Surgical Oncology, Department of Surgery, 3Division of Hematology and Oncology, Department of Medicine, 4Jonsson Comprehensive Cancer Center, 5Department of Molecular and Medical Pharmacology, 6David Geffen School of Medicine, University of California, Los Angeles, California; 7Melanoma Institute of Australia, 8Royal Prince Alfred Hospital, 9Westmead Millennium Institute, and 10Westmead Hospital, University of Sydney, New South Wales, Australia. · Pubmed 24265152
2013
  • *Melanoma Institute Australia Disciplines of †Pathology **Surgery, Sydney Medical School, The University of Sydney Departments of ‡Tissue Pathology and Diagnostic Oncology ††Melanoma and Surgical Oncology, Royal Prince Alfred Hospital §Royal College of Pathologists of Australasia, Sydney, NSW ¶¶Royal Adelaide Hospital and Flinders University, Adelaide, SA, Australia ∥Department of Pathology, Ninewells Hospital and Medical School, Dundee, Scotland ¶Cedars-Sinai Medical Center, Los Angeles, CA #Departments of Pathology and Dermatology, University of Texas-MD Anderson Cancer Center, Houston, TX ‡‡Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB ∥∥Department of Pathology, Capital District Health Authority and Dalhousie University, Halifax, NS, Canada §§Royal Victoria Hospital, Belfast, UK. · Pubmed 24061524
  • Department of Hepatobiliary and Upper Gastrointestinal Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 23813600
  • *Department of Dermatology †Robert H. Lurie Cancer Center ‡Department of Pediatric Dermatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago §§Abbott Molecular Laboratories, Des Plaines, IL Departments of §Pathology ∥Dermatology, University of Michigan Medical Center, Ann Arbor, MI ¶Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY **Department of Pathology, University of Pennsylvania, Philadelphia, PA ††Department of Pathology, Section of Dermatopathology ‡‡Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX ∥∥Department of Pathology and Laboratory Medicine, Dermatopathology, UCLA Medical Center, Los Angeles, CA #Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, The University of Sydney, NSW, Australia. · Pubmed 23797719
  • Department of Melanoma & Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 23688975
  • Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 23553375
  • Melanoma Institute Australia, The University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia. · Pubmed 23553208
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 22350600
  • Melanoma Institute Australia, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 22290565
  • Surgery (Melanoma and Surgical Oncology), University of Sydney, Melanoma Institute Australia and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, New South Wales. · Pubmed 22762064
  • Ludwig Institute for Cancer Research, Parkville, Vic., AustraliaDepartment of Surgery, Royal Melbourne Hospital, University of Melbourne, Vic., AustraliaJack Brockhoff Reconstructive Plastic Surgery Research Unit, Royal Melbourne Hospital and Department of Anatomy, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Vic., AustraliaTumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Vic., AustraliaTissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, AustraliaThe University of Sydney, Sydney, NSW, AustraliaMelanoma Institute Australia, North Sydney, NSW, AustraliaThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Vic., Australia. · Pubmed 22734806
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22716270
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22271204
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 21975320
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 21913010
2011
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21438911
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21412144
2010
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 20106719
  • Sydney Melanoma Unit and Melanoma Institute Australia, Royal Prince Alfred and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 19672660
  • Department of Medicine-Pulmonary Division, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 21061759
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 20823419
  • Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 20626102
  • Diagnostic Oncology and Tissue Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia. · Pubmed 20564101
  • Royal Prince Alfred Hospital, Sydney, Camperdown, NSW, Australia. · Pubmed 20425144
  • Sydney Melanoma Diagnostic Centre and Dermatology Department, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 20393481
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 20335819
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 19838163
2009
  • Royal Prince Alfred Hospital Discipline of Pathology, The University of Sydney, Camperdown Melanoma Institute Australia, New South Wales, Australia. · Pubmed 19851128
  • Melanoma Institute Australia and Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia · Pubmed 19786669
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 19783720
  • Discipline of Pathology, The University of Sydney, Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital and Melanoma Institute Australia. · Pubmed 19666944
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 19658180
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, New South Wales, Australia. · Pubmed 19561232
  • Melanoma Institute Australia incorporating the Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia. · Pubmed 19472395
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 19309398
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 19300224
  • Melanoma Institute Australia, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 19262412
  • Sydney Cancer Centre, Royal Prince Alfred Hospital, NSW, Australia. · Pubmed 18590949
2008
  • Royal Prince Alfred Hospital, Department of Anatomical Pathology, Camperdown, Sydney, NSW 2050, Australia. · Pubmed 18684064
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, Australia. · Pubmed 18854263
  • Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 18823042
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 18670348
  • Department of Anatomical Pathology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 18520228
  • Department of Anatomical Pathology; Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 18184262
  • Sydney Melanoma Unit, Sydney Cancer Centre, Gloucester House, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 18080717
  • Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, 2050, Australia. · Pubmed 18000712
  • Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · Pubmed 17990041
2007
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, Australia. · Pubmed 18043047
  • Sydney Melanoma Unit, Sydney Cancer Centre, Department of Anatomical Pathology, Royal Prince Alfred Hospital, and Discipline of Surgery, University of Sydney, NSW, Australia. · Pubmed 18027257
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 254 total) written by Dr. Richard Scolyer about Melanoma:

  • Tumor-associated B-cells induce tumor heterogeneity and therapy resistance. 2017
  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. 2017
  • Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress. 2017
  • MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy. 2017
  • Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis. 2017
  • Detection of desmoplastic melanoma with dermoscopy and reflectance confocal microscopy. 2017
  • Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia. 2017
  • Whole-genome landscapes of major melanoma subtypes. 2017
  • In Vivo Reflectance Confocal Microscopy for the Diagnosis of Melanoma and Melanotic Macules of the Lip. 2017
  • Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis. 2017
Show List of Full Article Records
Google Searches

Learn more about Dr. Richard Scolyer using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Royal Prince Alfred Hospital
Affiliation Timeline What is this?
Royal Prince Alfred Hospital
2017
  • Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX. · Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia. · Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL. · Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia. · Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA. · Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA. · Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia. · Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX. · Director General, Gustave Roussy Cancer Institute, Villejuif, France. · Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA. · Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 29028110
  • Translational Research Institute, Henan Provincial People's Hospital, Henan, China. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, New South Wales, Australia. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · School of Environmental and Life Sciences, The University of Newcastle, New South Wales, Australia. · Translational Research Institute, Henan Provincial People's Hospital, Henan, China. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. · Pubmed 28947420
  • Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · Institute of Molecular Medicine, University Hospital Bonn, University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, Magdeburg, Germany. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Developmental Pathology, Institute of Pathology, University of Bonn Medical School, Bonn, Germany. · Molecular Immunology and Cell Biology, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany. · Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · University of California Los Angeles (UCLA), Los Angeles, California. · Jonsson Comprehensive Cancer Center, Los Angeles, California. · Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. · Pubmed 28652246
  • Melanoma Institute Australia, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. · Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 28573666
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Plastic Surgery, Westmead Hospital, Sydney, NSW, Australia. · Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 28547563
  • Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. · Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia. · Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain. · Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Hospital at Westmead, The University of Sydney, Westmead, New South Wales Sydney, 2145, Australia. · Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia. · University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Melbourne, Victoria 3052, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales 2006, Australia. · Olivia Newton-John Cancer Research Institute, La Trobe University, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia. · Macquarie University, North Ryde, Sydney, New South Wales 2109, Australia. · Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales 2065, Australia. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria 3000, Australia. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, Australia. · Pubmed 28467829
  • Department of Dermatology, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile. · Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 28467525
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney. · Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney. · Melanoma Institute Australia, Sydney. · Sydney Medical School, The University of Sydney, Sydney. · Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 28327969
  • Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, University of Sydney, Westmead, NSW, Australia. · Pubmed 28067894
  • Program in Dermatopathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Melanoma Institute Australia, North Sydney, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Discipline of Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28032662
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia. · Pubmed 28024115
  • School of Mathematics and Statistics, The University of Sydney, Sydney, Australia. · Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA. · Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA. · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, Australia. · ARC Centre of Excellence for Mathematical & Statistical Frontiers. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Discipline Pathology, Sydney Medical School, The University of Sydney, Sydney, Australia. · Pubmed 27833072
  • Department of Biology, Shepherd University, Shepherdstown, WV, USA. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Robert C. Byrd Health Sciences Center, West Virginia University Cancer Institute, West Virginia University, Morgantown, WV, USA. · Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA. · Department of Pathology, Midwestern University, Downers Grove, IL, USA. · Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. · Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 27775691
  • The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: · Pubmed 27720652
  • Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. Electronic address: · Pubmed 28689094
2016
  • Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: · School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, Australia; Hunter Cancer Research Alliance (HCRA), Calvary Mater Newcastle, Waratah, Australia; Division of Anatomical Pathology, Pathology North (Hunter), New Lambton Heights, NSW, Australia. · Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Pubmed 27020382
  • Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. · Arizona State University, Phoenix, AZ, USA. · School of Medicine, Mayo Clinic, Rochester, MN, USA. · Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University, Durham, NC, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Melanoma Institute Australia, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. · Pubmed 27052645
  • Melanoma Institute Australia, North Sydney, Australia; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, North Sydney, Australia; The University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. Electronic address: · Pubmed 27020392
  • School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, Australia. · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. Electronic address: · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 26763444
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25956574
  • Department of Pathology, McGill University, Montreal, Quebec, Canada. · Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Melanoma Institute Australia, Royal Prince Alfred Hospital, and University of Sydney, Sydney, New South Wales, Australia. · Department of Immunology, Genetics and Pathology, and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France. · Centre for Research in Epidemiology and Population Health (CESP), INSERM, UMR 1018, Université Paris-Sud, Kremlin-Bicetre, France. · Centre de Recherche sur l'Inflammation, INSERM, UMR S 1149, Labex Inflamex, Université Paris-Diderot Sorbonne Paris-Cité, Paris, France. · CNRS, UMR 8200, Université Paris-Sud, Villejuif, France. · CNRS UMR 8200, Universite Paris-Sud, Gustave Roussy, Villejuif, France. · Hématopoïèse normale et pathologique, INSERM UMR 1170, Université Paris-Sud, Gustave Roussy, Villejuif, France. · Laboratory of Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium. · Laboratory of Computational Biology, VIB Center for the Biology of Disease, KU Leuven, Leuven, Belgium. · Department of Human Genetics, KU Leuven, Leuven, Belgium. · Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada. · Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, McGill University, Montreal, Quebec, Canada. · Pubmed 27974665
  • Department of Pathology and Dermatology, Moffitt Cancer Center/University of South Florida, Tampa, FL, United States. Electronic address: · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Dermatology Department, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Pubmed 27956274
  • Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Electronic address: · Protea Biosciences Inc, Morgantown, West Virginia. · Dermatopathologie Friedreichshafen, Friedrechshafen, Germany. · Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Department of Dermatology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York. · Department of Dermatology, Medical University of Graz, Graz, Austria. · Department of Dermatology, Medical University of Graz, Graz, Austria; Kempf und Pfaltz Histologische Diagnostik, Zürich, Switzerland. · Rabkin Dermatopathology Laboratory, Tarentum, Pennsylvania. · Department of Dermatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio; Cleveland Skin Pathology Laboratory Inc, Beachwood, Ohio. · Department of Pathology, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Emory University School of Medicine, Atlanta, Georgia; Children's Healthcare of Atlanta, Atlanta, Georgia. · Department of Surgery, Emory University School of Medicine, Atlanta, Georgia. · Universidad Complutense de Madrid Facultad de Medicina, Madrid, Spain. · Miraca Life Sciences, Newton, Massachusetts; Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts. · Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts. · Dermatopathologie Praticien Hospitalier, Département de Pathologie, Hôpital Necker-Enfants Malades, Paris, France. · Viollier Morges SA Lausanne, Lausanne, Switzerland. · DermDX New England, Boston, Massachusetts; Beacon Pathology, Dover, Massachusetts. · Department of Pathology, Hospital Obrero Nro 1, La Paz, Bolivia. · Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Pathology, University of Chile, Santiago, Chile. · Department of Dermatology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York; Muhlbauer Dermatopathology Laboratory, Pittsford, New York. · Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. · Department of Dermatology, Universidad Peruana Cayetano Heredia, Lima, Peru. · Department of Dermatology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut. · Mass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 27502312
  • Sydney Melanoma Diagnostic Centre and Dermatology Department, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Discipline of Dermatology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, 40 Rocklands Road, North Sydney, NSW, Australia. · Dermatology Unit, Second University of Naples, Naples, Italy. · Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova, University of Modena and Reggio Emilia, Modena, Italy. · Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. · Sydney School of Public Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Pubmed 27177158
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Medical Genomics, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Oncology, Royal North Shore and Mater Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 27151331
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 27075324
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia. Electronic address: · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 27020503
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, Australia; Hunter Cancer Research Alliance (HCRA), Calvary Mater Newcastle, Waratah, Australia; Division of Anatomical Pathology, Pathology North (Hunter), New Lambton Heights, Australia. Electronic address: · Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 27020383
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. · School of Mathematics and Statistics, The University of Sydney Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 26960397
  • Laboratory of Translational Cell and Tissue Research, University of Leuven, KUL, Leuven, Belgium. · Università Degli Studi di Milano-Bicocca, Milan, Italy. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Ludwig Institute for Cancer Research and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium. · Department of Surgical Oncology, UZ Gasthuisberg and KU Leuven, Leuven, Belgium. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26867783
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · The Strathfield Breast Centre, Strathfield, NSW, Australia. · Department of Breast and Endocrine Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia. · Department of Breast Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Surgery, Prince of Wales Hospital, Randwick, NSW, Australia. · Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. · Anatomical Pathology Department, Concord Repatriation General Hospital, Concord, NSW, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, Australia. · Pubmed 26588661
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Plastic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26561405
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Australia; Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. Electronic address: · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Australia; Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 27580960
2015
  • Melanoma Institute Australia, Sydney, Australia. · Department of Radiation Oncology, St Vincent's General Hospital, Sydney, Australia. · Genesis Cancer Care, Department of Radiation Oncology, Mater Hospital, Sydney, Australia. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Oslo University Hospital HF, The Norwegian Radium Hospital, Oslo, Norway. · Oslo University Hospital HF, The Norwegian Radium Hospital, Oslo, Norway. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Centre for Medical Psychology & Evidence-based Decision-making, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Psycho-Oncology Co-Operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · The Royal Melbourne Hospital & University of Melbourne, Parkville, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Centre for Medical Psychology & Evidence-based Decision-making, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Psycho-Oncology Co-Operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, Australia. · Concord Repatriation and General Hospital, Concord, Australia. · School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia. · Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Peter MacCallum Cancer Centre East Melbourne & University of Melbourne, Parkville, Australia. · Melanoma Institute Australia, Sydney, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Pubmed 25952979
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • School of Medicine and Public Health, The University of Newcastle, NSW 2308, Australia. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW 2308, Australia. · Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi 030013, China. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW 2006, Australia. · Children's Cancer Institute Australia for Medical Research, The University of New South Wales, Sydney, NSW 2052, Australia. · Pubmed 26573229
  • Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · National Human Genome Research Institute, US National Institutes of Health, Bethesda, Maryland, USA. · National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA. · Institute of Biochemistry, Food Science and Nutrition, Hebrew University, Rehovot, Israel. · Department of Biological Services, Weizmann Institute of Science, Rehovot, Israel. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. · Centre for Cancer Research, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 26502337
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Merck Research Laboratories, Palo Alto, CA, USA. · Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, NSW, Australia. · Pubmed 26403784
  • Department of Pathology, University of California, San Francisco, San Francisco, California, USA. · Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. · Five3 Genomics, LLC, Santa Cruz, California, USA. · Samsung Advanced Institute of Technology, Seoul, Korea. · Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA. · Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA. · Samsung Electronics Headquarters, Seoul, Korea. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Pubmed 26343386
  • NantOmics LLC, Santa Cruz, CA 95060; · Samsung Advanced Institute of Technology, Suwon-si, Gyeonggi-do, 443-803, Korea; · Department of Statistics, University of California, Berkeley, CA 94720-3860; · Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; · Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97239-30; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW 2050, Australia; · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Hematology and Oncology, University of California, San Francisco, CA 94143-1770; · Samsung Electronics, Inc. Seocho-gu, Seoul 137-857, Korea; · Department of Dermatology, University of California, San Francisco, CA 94115; · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Pathology, University of California, San Francisco, CA 94143-0511 · Pubmed 26286987
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Departments of Melanoma and Surgical Oncology, Camperdown, New South Wales, Australia [3] Mater Hospital, North Sydney, Sydney, New South Wales, Australia [4] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Kolling Institute, Royal North Shore Hospital, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25836739
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Poche Centre, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25827527
  • Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Howard Hughes Medical Institute NU Bioscientist Program, Weinberg College of Arts and Sciences, Northwestern University, Evanston, Illinois. · Department of Pathology, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Pubmed 25767211
  • School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. School of Life Science, Anhui Medical University, Anhui, China. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Shanxi, China. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. · Pubmed 25724678
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, New South Wales, Australia. Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · The Kinghorn Cancer Centre, Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25370473
  • Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA. · Sequencing Center, John Wayne Cancer Institute, Santa Monica, California, USA. · Melanoma Institute Australia and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Tissue Pathology and Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Department of Cell Research and Immunology, Tel-Aviv University, Tel-Aviv, Israel. · Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA; Sequencing Center, John Wayne Cancer Institute, Santa Monica, California, USA. Electronic address: · Pubmed 25243790
  • Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital, Sydney, Australia. · Westmead Hospital, Sydney, Australia. · Queensland Centre for Medical Genomics; Institute of Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Australia. · Canberra Hospital and Australian National University Medical School, Canberra, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital; Melanoma Institute Australia, Sydney, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow; Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom. · Melanoma Institute Australia; The University of Sydney and Westmead Institute for Cancer Research, Sydney, Australia · Pubmed 24821886
  • Melanoma Institute Australia, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 26072686
2014
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
  • School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW, Australia. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW, Australia. Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW, Australia. Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Taiyuan, Shanxi, China. · School of Medicine and Public Health, The University of Newcastle, NSW, Australia. · Pubmed 25365078
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America; The Group Health Research Institute, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia. · Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 24733413
  • School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · School of Mathematics and Statistics and Prince of Wales Clinical School, University of New South Wales, Kensington, NSW, 2052, Australia. · Discipline of Infectious Diseases and Immunology Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia. · Discipline of Dermatology, Bosch Institute, Faculty of Medicine, Sydney Medical School, Sydney, NSW, 2006, Australia. · Melanoma Institute Australia, North Sydney, NSW, 2060, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Westmead Institute of Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, 2145, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Pubmed 24435119
  • 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA. · 1] Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Westmead Institute for Cancer Research, NSW, Sydney, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Mater Hospital, Sydney, NSW, Australia [4] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA [3] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [4] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24434899
  • Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven (KU Leuven), Leuven, Belgium. · Surgical Oncology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Dermatology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium. · Embryo and Stem Cells, Department of Development and Regeneration, University of Leuven (KU Leuven), Leuven, Belgium. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Discipline of Surgery, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia. · Pubmed 24390218
  • 1] Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, University of Massachusetts Medical Center, Worcester, MA, USA. · Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Royal Prince Alfred Hospital, Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, Australia. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Divison of Endocrinology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 24390216
  • School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia. · Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Taiyuan, China. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24121273
  • Department of Dermatology, University of Duisburg-Essen, Essen, Germany. · Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · 1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23887304
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
  • Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Missenden Road, Sydney, NSW 2050, Australia. · Pubmed 24366302
2012
  • Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; The Melanoma Institute Australia, New South Wales, Australia. Electronic address: · Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia. · Department of Dermatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy. · Department of Pathology, University of Modena and Reggio Emilia, Reggio Emilia, Italy. · The Melanoma Institute Australia, New South Wales, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, Australia. · Department of Dermatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy; Department of Dermatology, University of Modena and Reggio Emilia, Reggio Emilia, Italy. · Pubmed 22718115
2011
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, NSW 2050, Australia. · Pubmed 21111957
2008
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 18697713
  • Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 18639451
2017
  • Lauren E. Haydu, Richard A. Scolyer, Serigne Lo, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, and John F. Thompson: The University of Sydney, Sydney; Richard A. Scolyer, Robyn P.M. Saw, and John F. Thompson, Royal Prince Alfred Hospital, Camperdown; Michael J. Quinn, The University of Wollongong, Wollongong, NSW, Australia; and Lauren E. Haydu, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28375785
2016
  • Departments of *Pathology ¶Surgery #Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY †Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ‡Melanoma Institute of Australia, North Sydney §Sydney Medical School, The University of Sydney, Sydney, NSW, Australia ∥Dartmouth College, Hanover, NH. · Pubmed 26872010
2015
  • 1Melanoma Institute Australia, North Sydney, NSW 2Sydney Medical School, The University of Sydney, Camperdown, NSW 3Immunogenomics Laboratory, Australian National University, Canberra, ACT 4Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Qld 5Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW 6Bioplatforms Australia, Macquarie University, North Ryde, NSW 7Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic 8The Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Vic 9Departments of Melanoma and Surgical Oncology 10Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; these authors contributed equally. · Pubmed 26517638
  • aDepartment of Dermatology, Westmead Hospital, Westmead bSydney Medical School, The University of Sydney cDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital dMelanoma Institute Australia eDepartment of Tissue Pathology and Diagnostic Oncology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, New South Wales, Sydney, Australia. · Pubmed 25380183
  • *Melanoma Institute Australia North Sydney †Sydney Medical School The University of Sydney ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital Sydney, NSW, Australia. · Pubmed 25871468
2014
  • aPeter Macallum Cancer Institute, East Melbourne bVictorian Melanoma Service, Alfred Hospital, Prahran cDepartment of Paediatrics, Murdoch Children's Research Institute, Royal Children's Hospital, The University of Melbourne, Parkville dThe Royal Children's Hospital, Flemington Road, Parkville, Victoria eMelanoma Institute Australia , Royal Prince Alfred Hospital, The University of Sydney, Sydney, New South Wales, Australia fDepartment of Medicine, Melanoma and Skin Cancer Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA. · Pubmed 24892957
  • Affiliations of authors: Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany (KGG, DS); Royal Prince Alfred Hospital, Camperdown, NSW, Australia (RAS); University of Sydney, Camperdown, NSW, Australia (RAS, JFT); Melanoma Institute Australia, North Sydney, NSW, Australia (RAS, JFT); Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA (KTF); Department of Pathology, and Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY (RM). · Pubmed 24511108
  • *Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands †Melanoma Institute Australia, Sydney, New South Wales, Australia Disciplines of ‡Surgery, and §Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; and ¶Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25072430
  • Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California (D.M.M., J.L.H., D.S.B.H.); Department of Tissue Oncology and Diagnostic Pathology (R.A.S., M.E.B., J.F.T.) and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia (J.F.T.); Sydney Medical School, The University of Sydney, Sydney, Australia (R.A.S., J.S.W., M.E.B., J.F.T.); Melanoma Institute Australia, Sydney, Australia (R.A.S., J.S.W.); Cellular and Molecular Biology Laboratory, Institute of Histology and Embryology, Mendoza, Argentina (M.R.); Tumor Biology Laboratory, Institute of Medicine and Experimental Biology of Cuyo, Mendoza, Argentina (L.M.V.-R.); Department of Pathology (R.M.), Center for Molecular Oncology (R.M.), and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York (R.M.); Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California (D.L.M.); Brain Tumor Center, Saint John's Health Center, Santa Monica, California (G.B., D.F.K.). · Pubmed 24968695
  • *Department of Dermatology †Robert H. Lurie Cancer Center †††Department of Preventive Medicine and the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL ‡Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY §Department of Pathology and Laboratory Medicine, Dermatopathology, UCLA Medical Center, Los Angeles ‡‡Departments of Pathology and Dermatology, University of California, San Francisco, San Francisco, CA ¶Pathology Service, Massachusetts General Hospital, Boston, MA #Department of Pathology, University of Pennsylvania, Philadelphia ¶¶Rabkin Dermatopathology Laboratory, P.C., Tarentum, PA Departments of **Pathology ††Dermatology, University of Michigan Medical Center, Ann Arbor, MI §§Department of Pathology, Section of Dermatopathology ∥∥Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX ∥Department of Histopathology, Royal Surrey County Hospital & Division of Clinical Medicine, University of Surrey, Guildford, Surrey, UK ##Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Melanoma Institute Australia and The University of Sydney, NSW, Australia ***Departments of Dermatology, Chonnam National University Medical School, Gwangju, Korea. · Pubmed 24618612
  • 1The University of Sydney, Sydney 2Melanoma Institute Australia, North Sydney 3Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia 4Canterbury Health Laboratories, Christchurch, New Zealand 5Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst 6Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 24614711
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
  • 1The Division of Dermatology, Department of Medicine, 2Division of Surgical Oncology, Department of Surgery, 3Division of Hematology and Oncology, Department of Medicine, 4Jonsson Comprehensive Cancer Center, 5Department of Molecular and Medical Pharmacology, 6David Geffen School of Medicine, University of California, Los Angeles, California; 7Melanoma Institute of Australia, 8Royal Prince Alfred Hospital, 9Westmead Millennium Institute, and 10Westmead Hospital, University of Sydney, New South Wales, Australia. · Pubmed 24265152
2013
  • *Melanoma Institute Australia Disciplines of †Pathology **Surgery, Sydney Medical School, The University of Sydney Departments of ‡Tissue Pathology and Diagnostic Oncology ††Melanoma and Surgical Oncology, Royal Prince Alfred Hospital §Royal College of Pathologists of Australasia, Sydney, NSW ¶¶Royal Adelaide Hospital and Flinders University, Adelaide, SA, Australia ∥Department of Pathology, Ninewells Hospital and Medical School, Dundee, Scotland ¶Cedars-Sinai Medical Center, Los Angeles, CA #Departments of Pathology and Dermatology, University of Texas-MD Anderson Cancer Center, Houston, TX ‡‡Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB ∥∥Department of Pathology, Capital District Health Authority and Dalhousie University, Halifax, NS, Canada §§Royal Victoria Hospital, Belfast, UK. · Pubmed 24061524
  • Department of Hepatobiliary and Upper Gastrointestinal Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 23813600
  • *Department of Dermatology †Robert H. Lurie Cancer Center ‡Department of Pediatric Dermatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago §§Abbott Molecular Laboratories, Des Plaines, IL Departments of §Pathology ∥Dermatology, University of Michigan Medical Center, Ann Arbor, MI ¶Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY **Department of Pathology, University of Pennsylvania, Philadelphia, PA ††Department of Pathology, Section of Dermatopathology ‡‡Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX ∥∥Department of Pathology and Laboratory Medicine, Dermatopathology, UCLA Medical Center, Los Angeles, CA #Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, The University of Sydney, NSW, Australia. · Pubmed 23797719
  • Department of Melanoma & Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 23688975
  • Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 23553375
  • Melanoma Institute Australia, The University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia. · Pubmed 23553208
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 22350600
  • Melanoma Institute Australia, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 22290565
  • Surgery (Melanoma and Surgical Oncology), University of Sydney, Melanoma Institute Australia and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, New South Wales. · Pubmed 22762064
  • Ludwig Institute for Cancer Research, Parkville, Vic., AustraliaDepartment of Surgery, Royal Melbourne Hospital, University of Melbourne, Vic., AustraliaJack Brockhoff Reconstructive Plastic Surgery Research Unit, Royal Melbourne Hospital and Department of Anatomy, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Vic., AustraliaTumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Vic., AustraliaTissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, AustraliaThe University of Sydney, Sydney, NSW, AustraliaMelanoma Institute Australia, North Sydney, NSW, AustraliaThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Vic., Australia. · Pubmed 22734806
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22716270
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22271204
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 21975320
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 21913010
2011
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21438911
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21412144
2010
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 20106719
  • Sydney Melanoma Unit and Melanoma Institute Australia, Royal Prince Alfred and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 19672660
  • Department of Medicine-Pulmonary Division, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 21061759
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 20823419
  • Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 20626102
  • Diagnostic Oncology and Tissue Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia. · Pubmed 20564101
  • Royal Prince Alfred Hospital, Sydney, Camperdown, NSW, Australia. · Pubmed 20425144
  • Sydney Melanoma Diagnostic Centre and Dermatology Department, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 20393481
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 20335819
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 19838163
2009
  • Royal Prince Alfred Hospital Discipline of Pathology, The University of Sydney, Camperdown Melanoma Institute Australia, New South Wales, Australia. · Pubmed 19851128
  • Melanoma Institute Australia and Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia · Pubmed 19786669
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 19783720
  • Discipline of Pathology, The University of Sydney, Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital and Melanoma Institute Australia. · Pubmed 19666944
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 19658180
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, New South Wales, Australia. · Pubmed 19561232
  • Melanoma Institute Australia incorporating the Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia. · Pubmed 19472395
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 19309398
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 19300224
  • Melanoma Institute Australia, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 19262412
  • Sydney Cancer Centre, Royal Prince Alfred Hospital, NSW, Australia. · Pubmed 18590949
2008
  • Royal Prince Alfred Hospital, Department of Anatomical Pathology, Camperdown, Sydney, NSW 2050, Australia. · Pubmed 18684064
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, Australia. · Pubmed 18854263
  • Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 18823042
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 18670348
  • Department of Anatomical Pathology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 18520228
  • Department of Anatomical Pathology; Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 18184262
  • Sydney Melanoma Unit, Sydney Cancer Centre, Gloucester House, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 18080717
  • Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, 2050, Australia. · Pubmed 18000712
  • Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · Pubmed 17990041
2007
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, Australia. · Pubmed 18043047
  • Sydney Melanoma Unit, Sydney Cancer Centre, Department of Anatomical Pathology, Royal Prince Alfred Hospital, and Discipline of Surgery, University of Sydney, NSW, Australia. · Pubmed 18027257
University of Sydney
2017
  • The Wistar Institute, Philadelphia, PA, 19104, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Department of Pathology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · New Jersey Institute of Technology, Newark, NJ, 07102, USA. · Department of Dermatology and Venereology, Karl Landsteiner University of Health Sciences, St. Pölten, A-3100, Austria. · Department of Radiology, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Dermatology and Venereology, The Rudolfstiftung Hospital, Teaching Hospital of the Medical University Vienna, Vienna, A-1030, Austria. · Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, A-5020, Austria. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02115, USA. · Melanoma Institute of Australia, and The University of Sydney, Sydney, 2065, Australia. · Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Abramson Cancer Center, Hospital of University of Pennsylvania, Philadelphia, PA, 19104, USA. · SRI International, Menlo Park, CA, 94025, USA. · CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, A-1090, Austria. · Department of Biochemistry, McGill University, Montreal, QC, Canada, H3A0G4. · Dermatology Research Center, University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, 4102, Australia. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer, Center, Houston, TX, 77040, USA. · Moffitt Cancer Center, Tampa, FL, 33612, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · Pubmed 28928360
  • Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX. · Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia. · Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL. · Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia. · Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA. · Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA. · Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia. · Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX. · Director General, Gustave Roussy Cancer Institute, Villejuif, France. · Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA. · Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 29028110
  • Translational Research Institute, Henan Provincial People's Hospital, Henan, China. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, New South Wales, Australia. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · School of Environmental and Life Sciences, The University of Newcastle, New South Wales, Australia. · Translational Research Institute, Henan Provincial People's Hospital, Henan, China. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. · Pubmed 28947420
  • Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · Institute of Molecular Medicine, University Hospital Bonn, University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, Magdeburg, Germany. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Developmental Pathology, Institute of Pathology, University of Bonn Medical School, Bonn, Germany. · Molecular Immunology and Cell Biology, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany. · Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · University of California Los Angeles (UCLA), Los Angeles, California. · Jonsson Comprehensive Cancer Center, Los Angeles, California. · Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. · Pubmed 28652246
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Microbiology and Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · The University of Queensland Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, Queensland, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, The University of Melbourne, Victoria, Australia. · Cancer Care Services, Royal Brisbane and Women's Hospital, Queensland, Australia. · Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Pubmed 28652244
  • Melanoma Institute Australia, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. · Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 28573666
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Plastic Surgery, Westmead Hospital, Sydney, NSW, Australia. · Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 28547563
  • Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. · Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia. · Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain. · Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Hospital at Westmead, The University of Sydney, Westmead, New South Wales Sydney, 2145, Australia. · Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia. · University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Melbourne, Victoria 3052, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales 2006, Australia. · Olivia Newton-John Cancer Research Institute, La Trobe University, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia. · Macquarie University, North Ryde, Sydney, New South Wales 2109, Australia. · Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales 2065, Australia. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria 3000, Australia. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, Australia. · Pubmed 28467829
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney. · Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney. · Melanoma Institute Australia, Sydney. · Sydney Medical School, The University of Sydney, Sydney. · Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 28327969
  • Melanoma Institute Australia, 40 Rockland Roads, North Sydney, NSW, 2060, Australia. · School of Medicine Sydney, The University of Notre Dame, Sydney, Australia. · Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, 40 Rockland Roads, North Sydney, NSW, 2060, Australia. · Sydney Medical School, The University of Sydney, Sydney, Australia. · Pubmed 28130620
  • Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, University of Sydney, Westmead, NSW, Australia. · Pubmed 28067894
  • Program in Dermatopathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Melanoma Institute Australia, North Sydney, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Discipline of Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28032662
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia. · Pubmed 28024115
  • School of Mathematics and Statistics, The University of Sydney, Sydney, Australia. · Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA. · Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA. · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, Australia. · ARC Centre of Excellence for Mathematical & Statistical Frontiers. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Discipline Pathology, Sydney Medical School, The University of Sydney, Sydney, Australia. · Pubmed 27833072
  • Department of Biology, Shepherd University, Shepherdstown, WV, USA. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Robert C. Byrd Health Sciences Center, West Virginia University Cancer Institute, West Virginia University, Morgantown, WV, USA. · Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA. · Department of Pathology, Midwestern University, Downers Grove, IL, USA. · Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. · Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 27775691
  • The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: · Pubmed 27720652
  • Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. Electronic address: · Pubmed 28689094
2016
  • Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: · School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, Australia; Hunter Cancer Research Alliance (HCRA), Calvary Mater Newcastle, Waratah, Australia; Division of Anatomical Pathology, Pathology North (Hunter), New Lambton Heights, NSW, Australia. · Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Pubmed 27020382
  • Faculty of Medicine and Health Sciences, Department of Biomedical Sciences, Macquarie University, 2 Technology Place, Sydney, NSW 2109, Australia; Melanoma Institute Australia, 40 Rocklands Road, Wollstonecraft, NSW 2065, Australia. · Melanoma Institute Australia, 40 Rocklands Road, Wollstonecraft, NSW 2065, Australia; The University of Sydney, Sydney, NSW 2006, Australia. · Melanoma Institute Australia, 40 Rocklands Road, Wollstonecraft, NSW 2065, Australia; The University of Sydney, Sydney, NSW 2006, Australia. Electronic address: · Pubmed 27232329
  • Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. · Arizona State University, Phoenix, AZ, USA. · School of Medicine, Mayo Clinic, Rochester, MN, USA. · Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University, Durham, NC, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Melanoma Institute Australia, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. · Pubmed 27052645
  • Melanoma Institute Australia, North Sydney, Australia; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, North Sydney, Australia; The University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. Electronic address: · Pubmed 27020392
  • School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, Australia. · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. Electronic address: · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 26763444
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25956574
  • Department of Pathology, McGill University, Montreal, Quebec, Canada. · Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Melanoma Institute Australia, Royal Prince Alfred Hospital, and University of Sydney, Sydney, New South Wales, Australia. · Department of Immunology, Genetics and Pathology, and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France. · Centre for Research in Epidemiology and Population Health (CESP), INSERM, UMR 1018, Université Paris-Sud, Kremlin-Bicetre, France. · Centre de Recherche sur l'Inflammation, INSERM, UMR S 1149, Labex Inflamex, Université Paris-Diderot Sorbonne Paris-Cité, Paris, France. · CNRS, UMR 8200, Université Paris-Sud, Villejuif, France. · CNRS UMR 8200, Universite Paris-Sud, Gustave Roussy, Villejuif, France. · Hématopoïèse normale et pathologique, INSERM UMR 1170, Université Paris-Sud, Gustave Roussy, Villejuif, France. · Laboratory of Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium. · Laboratory of Computational Biology, VIB Center for the Biology of Disease, KU Leuven, Leuven, Belgium. · Department of Human Genetics, KU Leuven, Leuven, Belgium. · Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada. · Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, McGill University, Montreal, Quebec, Canada. · Pubmed 27974665
  • Department of Pathology and Dermatology, Moffitt Cancer Center/University of South Florida, Tampa, FL, United States. Electronic address: · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Dermatology Department, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Pubmed 27956274
  • Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Electronic address: · Protea Biosciences Inc, Morgantown, West Virginia. · Dermatopathologie Friedreichshafen, Friedrechshafen, Germany. · Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Department of Dermatology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York. · Department of Dermatology, Medical University of Graz, Graz, Austria. · Department of Dermatology, Medical University of Graz, Graz, Austria; Kempf und Pfaltz Histologische Diagnostik, Zürich, Switzerland. · Rabkin Dermatopathology Laboratory, Tarentum, Pennsylvania. · Department of Dermatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio; Cleveland Skin Pathology Laboratory Inc, Beachwood, Ohio. · Department of Pathology, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Emory University School of Medicine, Atlanta, Georgia; Children's Healthcare of Atlanta, Atlanta, Georgia. · Department of Surgery, Emory University School of Medicine, Atlanta, Georgia. · Universidad Complutense de Madrid Facultad de Medicina, Madrid, Spain. · Miraca Life Sciences, Newton, Massachusetts; Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts. · Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts. · Dermatopathologie Praticien Hospitalier, Département de Pathologie, Hôpital Necker-Enfants Malades, Paris, France. · Viollier Morges SA Lausanne, Lausanne, Switzerland. · DermDX New England, Boston, Massachusetts; Beacon Pathology, Dover, Massachusetts. · Department of Pathology, Hospital Obrero Nro 1, La Paz, Bolivia. · Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Pathology, University of Chile, Santiago, Chile. · Department of Dermatology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York; Muhlbauer Dermatopathology Laboratory, Pittsford, New York. · Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. · Department of Dermatology, Universidad Peruana Cayetano Heredia, Lima, Peru. · Department of Dermatology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut. · Mass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 27502312
  • Sydney Melanoma Diagnostic Centre and Dermatology Department, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Discipline of Dermatology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, 40 Rocklands Road, North Sydney, NSW, Australia. · Dermatology Unit, Second University of Naples, Naples, Italy. · Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova, University of Modena and Reggio Emilia, Modena, Italy. · Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. · Sydney School of Public Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Pubmed 27177158
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Medical Genomics, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Oncology, Royal North Shore and Mater Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 27151331
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 27075324
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia. Electronic address: · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 27020503
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, Australia; Hunter Cancer Research Alliance (HCRA), Calvary Mater Newcastle, Waratah, Australia; Division of Anatomical Pathology, Pathology North (Hunter), New Lambton Heights, Australia. Electronic address: · Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 27020383
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. · School of Mathematics and Statistics, The University of Sydney Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 26960397
  • Laboratory of Translational Cell and Tissue Research, University of Leuven, KUL, Leuven, Belgium. · Università Degli Studi di Milano-Bicocca, Milan, Italy. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Ludwig Institute for Cancer Research and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium. · Department of Surgical Oncology, UZ Gasthuisberg and KU Leuven, Leuven, Belgium. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26867783
  • Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Duisburg-Essen, Germany. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Duisburg-Essen, Germany. · Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Duisburg-Essen, Germany. · Institute of Human Genetics, Medical University of Graz, Graz, Austria. · Tissue Pathology and Diagnostic Oncology, Camperdown, NSW, Australia. · The University of Sydney, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, Catholic University, Rome, Italy. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Duisburg-Essen, Germany. · Pubmed 26744134
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · The Strathfield Breast Centre, Strathfield, NSW, Australia. · Department of Breast and Endocrine Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia. · Department of Breast Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Surgery, Prince of Wales Hospital, Randwick, NSW, Australia. · Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. · Anatomical Pathology Department, Concord Repatriation General Hospital, Concord, NSW, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, Australia. · Pubmed 26588661
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Plastic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26561405
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Australia; Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. Electronic address: · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Australia; Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 27580960
2015
  • Division of Cancer Surgery, University of Melbourne Department of Surgery, East Melbourne, VIC, Australia; University of Melbourne, East Melbourne, VIC, Australia. Electronic address: · Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Centre for Biostatistics and Clinical Trials, East Melbourne, VIC, Australia. · Melanoma Institute of Australia, University of Sydney, Sydney, NSW, Australia. · Royal Adelaide Hospital, University of Adelaide, Adelaide, SA, Australia. · Christchurch Hospital, Christchurch, New Zealand. · Hospital Do Cancer, Sao Paulo, Brazil. · University Medical Centre Groningen, Groningen, Netherlands. · Pubmed 26206146
  • Melanoma Institute Australia, Sydney, Australia. · Department of Radiation Oncology, St Vincent's General Hospital, Sydney, Australia. · Genesis Cancer Care, Department of Radiation Oncology, Mater Hospital, Sydney, Australia. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Oslo University Hospital HF, The Norwegian Radium Hospital, Oslo, Norway. · Oslo University Hospital HF, The Norwegian Radium Hospital, Oslo, Norway. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Centre for Medical Psychology & Evidence-based Decision-making, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Psycho-Oncology Co-Operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · The Royal Melbourne Hospital & University of Melbourne, Parkville, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Centre for Medical Psychology & Evidence-based Decision-making, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Psycho-Oncology Co-Operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, Australia. · Concord Repatriation and General Hospital, Concord, Australia. · School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia. · Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Peter MacCallum Cancer Centre East Melbourne & University of Melbourne, Parkville, Australia. · Melanoma Institute Australia, Sydney, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Pubmed 25952979
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • School of Medicine and Public Health, The University of Newcastle, NSW 2308, Australia. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW 2308, Australia. · Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi 030013, China. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW 2006, Australia. · Children's Cancer Institute Australia for Medical Research, The University of New South Wales, Sydney, NSW 2052, Australia. · Pubmed 26573229
  • School of Medical Sciences, Edith Cowan University, Joondalup, Western Australia, Australia. · Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · School of Engineering, Edith Cowan University, Joondalup, Western Australia, Australia. · Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · Disciplines of Pathology, The University of Sydney, Sydney, New South Wales, Australia. · Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. · Department of Medical Oncology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia. · School of Medicine and Pharmacology, The University of Western Australia, Crawley, Western Australia, Australia. · Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · School of Pathology and Laboratory Medicine, The University of Western Australia, Crawley, Western Australia, Australia. · Pubmed 26524482
  • Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · National Human Genome Research Institute, US National Institutes of Health, Bethesda, Maryland, USA. · National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA. · Institute of Biochemistry, Food Science and Nutrition, Hebrew University, Rehovot, Israel. · Department of Biological Services, Weizmann Institute of Science, Rehovot, Israel. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. · Centre for Cancer Research, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 26502337
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Merck Research Laboratories, Palo Alto, CA, USA. · Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, NSW, Australia. · Pubmed 26403784
  • Department of Pathology, University of California, San Francisco, San Francisco, California, USA. · Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. · Five3 Genomics, LLC, Santa Cruz, California, USA. · Samsung Advanced Institute of Technology, Seoul, Korea. · Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA. · Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA. · Samsung Electronics Headquarters, Seoul, Korea. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Pubmed 26343386
  • Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany. · Melanoma Institute Australia, Sydney, NSW, Australia ; The University of Sydney, Sydney Medical School, Sydney, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany ; Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · Surgical Oncology Group, The University of Queensland, School of Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland, Australia. · Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Pubmed 26288839
  • NantOmics LLC, Santa Cruz, CA 95060; · Samsung Advanced Institute of Technology, Suwon-si, Gyeonggi-do, 443-803, Korea; · Department of Statistics, University of California, Berkeley, CA 94720-3860; · Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; · Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97239-30; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW 2050, Australia; · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Hematology and Oncology, University of California, San Francisco, CA 94143-1770; · Samsung Electronics, Inc. Seocho-gu, Seoul 137-857, Korea; · Department of Dermatology, University of California, San Francisco, CA 94115; · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Pathology, University of California, San Francisco, CA 94143-0511 · Pubmed 26286987
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • Department of Pathology, Yale School of Medicine, New Haven, Connecticut. · Department of Pathology, Yale School of Medicine, New Haven, Connecticut. · Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. · Melanoma Institute of Australia, Sydney, New South Wales, Australia. Discipline of Pathology, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia. Discipline of Medicine, The University of Sydney, Sydney, New South Wales, Australia. · Department of Pathology, Yale School of Medicine, New Haven, Connecticut. Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. · Pubmed 25948295
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Departments of Melanoma and Surgical Oncology, Camperdown, New South Wales, Australia [3] Mater Hospital, North Sydney, Sydney, New South Wales, Australia [4] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Kolling Institute, Royal North Shore Hospital, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25836739
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Poche Centre, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25827527
  • Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Howard Hughes Medical Institute NU Bioscientist Program, Weinberg College of Arts and Sciences, Northwestern University, Evanston, Illinois. · Department of Pathology, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Pubmed 25767211
  • School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. School of Life Science, Anhui Medical University, Anhui, China. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Shanxi, China. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia. · Pubmed 25724678
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, New South Wales, Australia. Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · The Kinghorn Cancer Centre, Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25370473
  • Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA. · Sequencing Center, John Wayne Cancer Institute, Santa Monica, California, USA. · Melanoma Institute Australia and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Tissue Pathology and Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Department of Cell Research and Immunology, Tel-Aviv University, Tel-Aviv, Israel. · Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA; Sequencing Center, John Wayne Cancer Institute, Santa Monica, California, USA. Electronic address: · Pubmed 25243790
  • Melanoma Institute Australia, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 26072686
2014
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
  • School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW, Australia. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW, Australia. Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Discipline of Pathology, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW, Australia. Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Taiyuan, Shanxi, China. · School of Medicine and Public Health, The University of Newcastle, NSW, Australia. · Pubmed 25365078
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America; The Group Health Research Institute, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia. · Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 24733413
  • School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · School of Mathematics and Statistics and Prince of Wales Clinical School, University of New South Wales, Kensington, NSW, 2052, Australia. · Discipline of Infectious Diseases and Immunology Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia. · Discipline of Dermatology, Bosch Institute, Faculty of Medicine, Sydney Medical School, Sydney, NSW, 2006, Australia. · Melanoma Institute Australia, North Sydney, NSW, 2060, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Westmead Institute of Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, 2145, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Pubmed 24435119
  • 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA. · 1] Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Westmead Institute for Cancer Research, NSW, Sydney, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Mater Hospital, Sydney, NSW, Australia [4] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA [3] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [4] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24434899
  • Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven (KU Leuven), Leuven, Belgium. · Surgical Oncology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Dermatology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium. · Embryo and Stem Cells, Department of Development and Regeneration, University of Leuven (KU Leuven), Leuven, Belgium. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Discipline of Surgery, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia. · Pubmed 24390218
  • 1] Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, University of Massachusetts Medical Center, Worcester, MA, USA. · Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Royal Prince Alfred Hospital, Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, Australia. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Divison of Endocrinology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 24390216
  • School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia. · Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Taiyuan, China. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24121273
  • Department of Dermatology, University of Duisburg-Essen, Essen, Germany. · Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · 1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23887304
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
  • Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Missenden Road, Sydney, NSW 2050, Australia. · Pubmed 24366302
2012
  • Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; The Melanoma Institute Australia, New South Wales, Australia. Electronic address: · Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia. · Department of Dermatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy. · Department of Pathology, University of Modena and Reggio Emilia, Reggio Emilia, Italy. · The Melanoma Institute Australia, New South Wales, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, Australia. · Department of Dermatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy; Department of Dermatology, University of Modena and Reggio Emilia, Reggio Emilia, Italy. · Pubmed 22718115
2017
  • Lauren E. Haydu, Richard A. Scolyer, Serigne Lo, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, and John F. Thompson: The University of Sydney, Sydney; Richard A. Scolyer, Robyn P.M. Saw, and John F. Thompson, Royal Prince Alfred Hospital, Camperdown; Michael J. Quinn, The University of Wollongong, Wollongong, NSW, Australia; and Lauren E. Haydu, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28375785
2016
  • Departments of *Pathology ¶Surgery #Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY †Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ‡Melanoma Institute of Australia, North Sydney §Sydney Medical School, The University of Sydney, Sydney, NSW, Australia ∥Dartmouth College, Hanover, NH. · Pubmed 26872010
2015
  • 1Melanoma Institute Australia, North Sydney, NSW 2Sydney Medical School, The University of Sydney, Camperdown, NSW 3Immunogenomics Laboratory, Australian National University, Canberra, ACT 4Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Qld 5Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW 6Bioplatforms Australia, Macquarie University, North Ryde, NSW 7Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic 8The Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Vic 9Departments of Melanoma and Surgical Oncology 10Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; these authors contributed equally. · Pubmed 26517638
  • Westmead Millennium Institute, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25490969
  • Melanoma Institute Australia, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25477049
  • aDepartment of Dermatology, Westmead Hospital, Westmead bSydney Medical School, The University of Sydney cDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital dMelanoma Institute Australia eDepartment of Tissue Pathology and Diagnostic Oncology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, New South Wales, Sydney, Australia. · Pubmed 25380183
  • School of Mathematics & Statistics, The University of Sydney, Sydney, NSW, Australia. · Pubmed 24975271
  • *Melanoma Institute Australia North Sydney †Sydney Medical School The University of Sydney ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital Sydney, NSW, Australia. · Pubmed 25871468
2014
  • aPeter Macallum Cancer Institute, East Melbourne bVictorian Melanoma Service, Alfred Hospital, Prahran cDepartment of Paediatrics, Murdoch Children's Research Institute, Royal Children's Hospital, The University of Melbourne, Parkville dThe Royal Children's Hospital, Flemington Road, Parkville, Victoria eMelanoma Institute Australia , Royal Prince Alfred Hospital, The University of Sydney, Sydney, New South Wales, Australia fDepartment of Medicine, Melanoma and Skin Cancer Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA. · Pubmed 24892957
  • Affiliations of authors: Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany (KGG, DS); Royal Prince Alfred Hospital, Camperdown, NSW, Australia (RAS); University of Sydney, Camperdown, NSW, Australia (RAS, JFT); Melanoma Institute Australia, North Sydney, NSW, Australia (RAS, JFT); Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA (KTF); Department of Pathology, and Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY (RM). · Pubmed 24511108
  • *Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands †Melanoma Institute Australia, Sydney, New South Wales, Australia Disciplines of ‡Surgery, and §Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; and ¶Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25072430
  • School of Molecular Bioscience, University of Sydney, Sydney, NSW, Australia. · Pubmed 24995518
  • Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California (D.M.M., J.L.H., D.S.B.H.); Department of Tissue Oncology and Diagnostic Pathology (R.A.S., M.E.B., J.F.T.) and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia (J.F.T.); Sydney Medical School, The University of Sydney, Sydney, Australia (R.A.S., J.S.W., M.E.B., J.F.T.); Melanoma Institute Australia, Sydney, Australia (R.A.S., J.S.W.); Cellular and Molecular Biology Laboratory, Institute of Histology and Embryology, Mendoza, Argentina (M.R.); Tumor Biology Laboratory, Institute of Medicine and Experimental Biology of Cuyo, Mendoza, Argentina (L.M.V.-R.); Department of Pathology (R.M.), Center for Molecular Oncology (R.M.), and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York (R.M.); Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California (D.L.M.); Brain Tumor Center, Saint John's Health Center, Santa Monica, California (G.B., D.F.K.). · Pubmed 24968695
  • Discipline of Physiology, Faculty of Medicine, The University of Sydney and Bosch Institute, N543 Anderson Stuart Bldg (F13), Sydney, NSW 2006, Australia. · Pubmed 24679002
  • Melanoma Institute Australia, Poche Centre, 40 Rocklands Road, North Sydney, NSW, 2060, Australia; Department of Sydney Melanoma Diagnostic Centre, Missenden Road Camperdown, NSW, 2050, Australia; Discipline of Dermatology, The University of Sydney, Sydney, NSW, Australia. · Pubmed 24641247
  • *Melanoma Institute Australia †Sydney Medical School, The University of Sydney, Sydney ‡Nuclear Medicine and Diagnostic Ultrasound, RPAH Medical Centre, Newtown, New South Wales, Australia. · Pubmed 24633018
  • *Department of Dermatology †Robert H. Lurie Cancer Center †††Department of Preventive Medicine and the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL ‡Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY §Department of Pathology and Laboratory Medicine, Dermatopathology, UCLA Medical Center, Los Angeles ‡‡Departments of Pathology and Dermatology, University of California, San Francisco, San Francisco, CA ¶Pathology Service, Massachusetts General Hospital, Boston, MA #Department of Pathology, University of Pennsylvania, Philadelphia ¶¶Rabkin Dermatopathology Laboratory, P.C., Tarentum, PA Departments of **Pathology ††Dermatology, University of Michigan Medical Center, Ann Arbor, MI §§Department of Pathology, Section of Dermatopathology ∥∥Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX ∥Department of Histopathology, Royal Surrey County Hospital & Division of Clinical Medicine, University of Surrey, Guildford, Surrey, UK ##Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Melanoma Institute Australia and The University of Sydney, NSW, Australia ***Departments of Dermatology, Chonnam National University Medical School, Gwangju, Korea. · Pubmed 24618612
  • 1The University of Sydney, Sydney 2Melanoma Institute Australia, North Sydney 3Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia 4Canterbury Health Laboratories, Christchurch, New Zealand 5Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst 6Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 24614711
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
  • 1The Division of Dermatology, Department of Medicine, 2Division of Surgical Oncology, Department of Surgery, 3Division of Hematology and Oncology, Department of Medicine, 4Jonsson Comprehensive Cancer Center, 5Department of Molecular and Medical Pharmacology, 6David Geffen School of Medicine, University of California, Los Angeles, California; 7Melanoma Institute of Australia, 8Royal Prince Alfred Hospital, 9Westmead Millennium Institute, and 10Westmead Hospital, University of Sydney, New South Wales, Australia. · Pubmed 24265152
2013
  • *Melanoma Institute Australia Disciplines of †Pathology **Surgery, Sydney Medical School, The University of Sydney Departments of ‡Tissue Pathology and Diagnostic Oncology ††Melanoma and Surgical Oncology, Royal Prince Alfred Hospital §Royal College of Pathologists of Australasia, Sydney, NSW ¶¶Royal Adelaide Hospital and Flinders University, Adelaide, SA, Australia ∥Department of Pathology, Ninewells Hospital and Medical School, Dundee, Scotland ¶Cedars-Sinai Medical Center, Los Angeles, CA #Departments of Pathology and Dermatology, University of Texas-MD Anderson Cancer Center, Houston, TX ‡‡Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB ∥∥Department of Pathology, Capital District Health Authority and Dalhousie University, Halifax, NS, Canada §§Royal Victoria Hospital, Belfast, UK. · Pubmed 24061524
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23298266
  • *Department of Dermatology †Robert H. Lurie Cancer Center ‡Department of Pediatric Dermatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago §§Abbott Molecular Laboratories, Des Plaines, IL Departments of §Pathology ∥Dermatology, University of Michigan Medical Center, Ann Arbor, MI ¶Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY **Department of Pathology, University of Pennsylvania, Philadelphia, PA ††Department of Pathology, Section of Dermatopathology ‡‡Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX ∥∥Department of Pathology and Laboratory Medicine, Dermatopathology, UCLA Medical Center, Los Angeles, CA #Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, The University of Sydney, NSW, Australia. · Pubmed 23797719
  • Sydney Medical School, The University of Sydney at Westmead Millennium Institute for Medical Research, Sydney, NSW, Australia. · Pubmed 23738911
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23557327
  • Melanoma Institute Australia, The University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia. · Pubmed 23553208
  • University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 23190890
  • Melanoma Institute Australia and Westmead Hospital, 40 Rocklands Rd, North Sydney, NSW 2060, Australia. · Pubmed 23026937
  • The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Pubmed 22931913
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Sydney Medical School, The University of Sydney at Westmead Millennium Institute, Sydney, New South Wales, Australia. · Pubmed 21956122
  • Department of Dermatology, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 22804352
  • Surgery (Melanoma and Surgical Oncology), University of Sydney, Melanoma Institute Australia and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, New South Wales. · Pubmed 22762064
  • Ludwig Institute for Cancer Research, Parkville, Vic., AustraliaDepartment of Surgery, Royal Melbourne Hospital, University of Melbourne, Vic., AustraliaJack Brockhoff Reconstructive Plastic Surgery Research Unit, Royal Melbourne Hospital and Department of Anatomy, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Vic., AustraliaTumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Vic., AustraliaTissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, AustraliaThe University of Sydney, Sydney, NSW, AustraliaMelanoma Institute Australia, North Sydney, NSW, AustraliaThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Vic., Australia. · Pubmed 22734806
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22716270
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22271204
2011
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia. · Pubmed 21343559
2010
  • Sydney Melanoma Unit and Melanoma Institute Australia, Royal Prince Alfred and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 19672660
  • Department of Medicine-Pulmonary Division, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 21061759
  • The University of Sydney, Sydney, NSW, Australia. · Pubmed 20546342
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 20478260
  • School of Molecular and Microbial Biosciences, The University of Sydney, NSW, Australia. · Pubmed 20363224
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 20335819
2009
  • Royal Prince Alfred Hospital Discipline of Pathology, The University of Sydney, Camperdown Melanoma Institute Australia, New South Wales, Australia. · Pubmed 19851128
  • Discipline of Pathology, The University of Sydney, Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital and Melanoma Institute Australia. · Pubmed 19666944
  • Melanoma Institute of Australia, and University of Sydney, North Sydney, Australia. · Pubmed 19247037
  • Westmead Institute for Cancer Research, University of Sydney, Westmead Millennium Institute and Westmead Hospital, Australia. · Pubmed 19149898
2007
  • Sydney Melanoma Unit, Sydney Cancer Centre, Department of Anatomical Pathology, Royal Prince Alfred Hospital, and Discipline of Surgery, University of Sydney, NSW, Australia. · Pubmed 18027257
  • Discipline of Pathology, Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia. · Pubmed 17384650
Mater Hospital
2017
  • Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX. · Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia. · Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL. · Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia. · Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA. · Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA. · Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia. · Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX. · Director General, Gustave Roussy Cancer Institute, Villejuif, France. · Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA. · Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 29028110
  • Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · Institute of Molecular Medicine, University Hospital Bonn, University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, Magdeburg, Germany. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Developmental Pathology, Institute of Pathology, University of Bonn Medical School, Bonn, Germany. · Molecular Immunology and Cell Biology, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany. · Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · University of California Los Angeles (UCLA), Los Angeles, California. · Jonsson Comprehensive Cancer Center, Los Angeles, California. · Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. · Pubmed 28652246
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Microbiology and Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · The University of Queensland Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, Queensland, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, The University of Melbourne, Victoria, Australia. · Cancer Care Services, Royal Brisbane and Women's Hospital, Queensland, Australia. · Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Pubmed 28652244
  • Melanoma Institute Australia, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. · Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 28573666
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Plastic Surgery, Westmead Hospital, Sydney, NSW, Australia. · Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 28547563
  • Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. · Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia. · Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain. · Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Hospital at Westmead, The University of Sydney, Westmead, New South Wales Sydney, 2145, Australia. · Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia. · University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Melbourne, Victoria 3052, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales 2006, Australia. · Olivia Newton-John Cancer Research Institute, La Trobe University, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia. · Macquarie University, North Ryde, Sydney, New South Wales 2109, Australia. · Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales 2065, Australia. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria 3000, Australia. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, Australia. · Pubmed 28467829
  • Department of Dermatology, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile. · Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 28467525
  • Melanoma Institute Australia, 40 Rockland Roads, North Sydney, NSW, 2060, Australia. · School of Medicine Sydney, The University of Notre Dame, Sydney, Australia. · Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, 40 Rockland Roads, North Sydney, NSW, 2060, Australia. · Sydney Medical School, The University of Sydney, Sydney, Australia. · Pubmed 28130620
  • Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, University of Sydney, Westmead, NSW, Australia. · Pubmed 28067894
  • Program in Dermatopathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Melanoma Institute Australia, North Sydney, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Discipline of Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28032662
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia. · Pubmed 28024115
  • Department of Biology, Shepherd University, Shepherdstown, WV, USA. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Robert C. Byrd Health Sciences Center, West Virginia University Cancer Institute, West Virginia University, Morgantown, WV, USA. · Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA. · Department of Pathology, Midwestern University, Downers Grove, IL, USA. · Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. · Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 27775691
  • The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · The Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: · Pubmed 27720652
  • Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. Electronic address: · Pubmed 28689094
2016
  • Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: · School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, Australia; Hunter Cancer Research Alliance (HCRA), Calvary Mater Newcastle, Waratah, Australia; Division of Anatomical Pathology, Pathology North (Hunter), New Lambton Heights, NSW, Australia. · Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Pubmed 27020382
  • Faculty of Medicine and Health Sciences, Department of Biomedical Sciences, Macquarie University, 2 Technology Place, Sydney, NSW 2109, Australia; Melanoma Institute Australia, 40 Rocklands Road, Wollstonecraft, NSW 2065, Australia. · Melanoma Institute Australia, 40 Rocklands Road, Wollstonecraft, NSW 2065, Australia; The University of Sydney, Sydney, NSW 2006, Australia. · Melanoma Institute Australia, 40 Rocklands Road, Wollstonecraft, NSW 2065, Australia; The University of Sydney, Sydney, NSW 2006, Australia. Electronic address: · Pubmed 27232329
  • Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. · Arizona State University, Phoenix, AZ, USA. · School of Medicine, Mayo Clinic, Rochester, MN, USA. · Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University, Durham, NC, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Melanoma Institute Australia, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. · Pubmed 27052645
  • Melanoma Institute Australia, North Sydney, Australia; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, North Sydney, Australia; The University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. Electronic address: · Pubmed 27020392
  • School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, Australia. · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. Electronic address: · The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 26763444
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25956574
  • Department of Pathology, McGill University, Montreal, Quebec, Canada. · Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Melanoma Institute Australia, Royal Prince Alfred Hospital, and University of Sydney, Sydney, New South Wales, Australia. · Department of Immunology, Genetics and Pathology, and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France. · Centre for Research in Epidemiology and Population Health (CESP), INSERM, UMR 1018, Université Paris-Sud, Kremlin-Bicetre, France. · Centre de Recherche sur l'Inflammation, INSERM, UMR S 1149, Labex Inflamex, Université Paris-Diderot Sorbonne Paris-Cité, Paris, France. · CNRS, UMR 8200, Université Paris-Sud, Villejuif, France. · CNRS UMR 8200, Universite Paris-Sud, Gustave Roussy, Villejuif, France. · Hématopoïèse normale et pathologique, INSERM UMR 1170, Université Paris-Sud, Gustave Roussy, Villejuif, France. · Laboratory of Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium. · Laboratory of Computational Biology, VIB Center for the Biology of Disease, KU Leuven, Leuven, Belgium. · Department of Human Genetics, KU Leuven, Leuven, Belgium. · Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada. · Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, McGill University, Montreal, Quebec, Canada. · Pubmed 27974665
  • Department of Pathology and Dermatology, Moffitt Cancer Center/University of South Florida, Tampa, FL, United States. Electronic address: · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Dermatology Department, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. · Pubmed 27956274
  • Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Electronic address: · Protea Biosciences Inc, Morgantown, West Virginia. · Dermatopathologie Friedreichshafen, Friedrechshafen, Germany. · Melanoma Institute Australia, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Department of Dermatology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York. · Department of Dermatology, Medical University of Graz, Graz, Austria. · Department of Dermatology, Medical University of Graz, Graz, Austria; Kempf und Pfaltz Histologische Diagnostik, Zürich, Switzerland. · Rabkin Dermatopathology Laboratory, Tarentum, Pennsylvania. · Department of Dermatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio; Cleveland Skin Pathology Laboratory Inc, Beachwood, Ohio. · Department of Pathology, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Emory University School of Medicine, Atlanta, Georgia; Children's Healthcare of Atlanta, Atlanta, Georgia. · Department of Surgery, Emory University School of Medicine, Atlanta, Georgia. · Universidad Complutense de Madrid Facultad de Medicina, Madrid, Spain. · Miraca Life Sciences, Newton, Massachusetts; Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts. · Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts. · Dermatopathologie Praticien Hospitalier, Département de Pathologie, Hôpital Necker-Enfants Malades, Paris, France. · Viollier Morges SA Lausanne, Lausanne, Switzerland. · DermDX New England, Boston, Massachusetts; Beacon Pathology, Dover, Massachusetts. · Department of Pathology, Hospital Obrero Nro 1, La Paz, Bolivia. · Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Pathology, University of Chile, Santiago, Chile. · Department of Dermatology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York; Muhlbauer Dermatopathology Laboratory, Pittsford, New York. · Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. · Department of Dermatology, Universidad Peruana Cayetano Heredia, Lima, Peru. · Department of Dermatology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut. · Mass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 27502312
  • Sydney Melanoma Diagnostic Centre and Dermatology Department, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Discipline of Dermatology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, 40 Rocklands Road, North Sydney, NSW, Australia. · Dermatology Unit, Second University of Naples, Naples, Italy. · Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova, University of Modena and Reggio Emilia, Modena, Italy. · Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. · Sydney School of Public Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Pubmed 27177158
  • The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Qld, Australia. · IQ Pathology, Brisbane, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Department of Pathology, Ege University, Izmir, Turkey. · Department of Dermatology, Ege University, Izmir, Turkey. · Dermatology Research Centre, Translational Research Institute, The University of Queensland School of Medicine, Brisbane, Qld, Australia. · Pubmed 27166757
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Medical Genomics, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Oncology, Royal North Shore and Mater Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 27151331
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 27075324
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia. Electronic address: · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Medicine, Sydney Medical School, The University of Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 27020503
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, Australia; Hunter Cancer Research Alliance (HCRA), Calvary Mater Newcastle, Waratah, Australia; Division of Anatomical Pathology, Pathology North (Hunter), New Lambton Heights, Australia. Electronic address: · Melanoma Institute Australia, North Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 27020383
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. · School of Mathematics and Statistics, The University of Sydney Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 26960397
  • Laboratory of Translational Cell and Tissue Research, University of Leuven, KUL, Leuven, Belgium. · Università Degli Studi di Milano-Bicocca, Milan, Italy. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Ludwig Institute for Cancer Research and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium. · Department of Surgical Oncology, UZ Gasthuisberg and KU Leuven, Leuven, Belgium. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26867783
  • Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Duisburg-Essen, Germany. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Duisburg-Essen, Germany. · Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Duisburg-Essen, Germany. · Institute of Human Genetics, Medical University of Graz, Graz, Austria. · Tissue Pathology and Diagnostic Oncology, Camperdown, NSW, Australia. · The University of Sydney, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, Catholic University, Rome, Italy. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Duisburg-Essen, Germany. · Pubmed 26744134
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · The Strathfield Breast Centre, Strathfield, NSW, Australia. · Department of Breast and Endocrine Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia. · Department of Breast Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Surgery, Prince of Wales Hospital, Randwick, NSW, Australia. · Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. · Anatomical Pathology Department, Concord Repatriation General Hospital, Concord, NSW, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, Australia. · Pubmed 26588661
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Plastic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26561405
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Australia; Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. Electronic address: · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Australia; Melanoma Institute Australia, Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 27580960
2015
  • Melanoma Institute Australia, Sydney, Australia. · Department of Radiation Oncology, St Vincent's General Hospital, Sydney, Australia. · Genesis Cancer Care, Department of Radiation Oncology, Mater Hospital, Sydney, Australia. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Oslo University Hospital HF, The Norwegian Radium Hospital, Oslo, Norway. · Oslo University Hospital HF, The Norwegian Radium Hospital, Oslo, Norway. · Trans-Tasman Radiation Oncology Group (TROG), Newcastle, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Centre for Medical Psychology & Evidence-based Decision-making, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Psycho-Oncology Co-Operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · The Royal Melbourne Hospital & University of Melbourne, Parkville, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Centre for Medical Psychology & Evidence-based Decision-making, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia. · Psycho-Oncology Co-Operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, Australia. · Concord Repatriation and General Hospital, Concord, Australia. · School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia. · Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Peter MacCallum Cancer Centre East Melbourne & University of Melbourne, Parkville, Australia. · Melanoma Institute Australia, Sydney, Australia. · Sydney Medical School, |The University of Sydney, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Australia and New Zealand Melanoma Trials Group (ANZMTG), North Sydney, Australia. · Pubmed 25952979
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • School of Medical Sciences, Edith Cowan University, Joondalup, Western Australia, Australia. · Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · School of Engineering, Edith Cowan University, Joondalup, Western Australia, Australia. · Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · Disciplines of Pathology, The University of Sydney, Sydney, New South Wales, Australia. · Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. · Department of Medical Oncology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia. · School of Medicine and Pharmacology, The University of Western Australia, Crawley, Western Australia, Australia. · Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · School of Pathology and Laboratory Medicine, The University of Western Australia, Crawley, Western Australia, Australia. · Pubmed 26524482
  • Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · National Human Genome Research Institute, US National Institutes of Health, Bethesda, Maryland, USA. · National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA. · Institute of Biochemistry, Food Science and Nutrition, Hebrew University, Rehovot, Israel. · Department of Biological Services, Weizmann Institute of Science, Rehovot, Israel. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. · Centre for Cancer Research, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 26502337
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Merck Research Laboratories, Palo Alto, CA, USA. · Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, NSW, Australia. · Pubmed 26403784
  • Department of Pathology, University of California, San Francisco, San Francisco, California, USA. · Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. · Five3 Genomics, LLC, Santa Cruz, California, USA. · Samsung Advanced Institute of Technology, Seoul, Korea. · Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA. · Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA. · Samsung Electronics Headquarters, Seoul, Korea. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Pubmed 26343386
  • Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany. · Melanoma Institute Australia, Sydney, NSW, Australia ; The University of Sydney, Sydney Medical School, Sydney, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany ; Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · Surgical Oncology Group, The University of Queensland, School of Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland, Australia. · Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Pubmed 26288839
  • NantOmics LLC, Santa Cruz, CA 95060; · Samsung Advanced Institute of Technology, Suwon-si, Gyeonggi-do, 443-803, Korea; · Department of Statistics, University of California, Berkeley, CA 94720-3860; · Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; · Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97239-30; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW 2050, Australia; · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Hematology and Oncology, University of California, San Francisco, CA 94143-1770; · Samsung Electronics, Inc. Seocho-gu, Seoul 137-857, Korea; · Department of Dermatology, University of California, San Francisco, CA 94115; · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Pathology, University of California, San Francisco, CA 94143-0511 · Pubmed 26286987
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Departments of Melanoma and Surgical Oncology, Camperdown, New South Wales, Australia [3] Mater Hospital, North Sydney, Sydney, New South Wales, Australia [4] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Kolling Institute, Royal North Shore Hospital, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25836739
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Poche Centre, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25827527
  • Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Howard Hughes Medical Institute NU Bioscientist Program, Weinberg College of Arts and Sciences, Northwestern University, Evanston, Illinois. · Department of Pathology, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Program in Cancer Biology and Epigenomics, Stanley Manne Children's Research Institute at Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Pubmed 25767211
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, New South Wales, Australia. Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · The Kinghorn Cancer Centre, Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25370473
  • Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA. · Sequencing Center, John Wayne Cancer Institute, Santa Monica, California, USA. · Melanoma Institute Australia and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Tissue Pathology and Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Department of Cell Research and Immunology, Tel-Aviv University, Tel-Aviv, Israel. · Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA; Sequencing Center, John Wayne Cancer Institute, Santa Monica, California, USA. Electronic address: · Pubmed 25243790
  • Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital, Sydney, Australia. · Westmead Hospital, Sydney, Australia. · Queensland Centre for Medical Genomics; Institute of Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Australia. · Canberra Hospital and Australian National University Medical School, Canberra, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital; Melanoma Institute Australia, Sydney, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow; Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom. · Melanoma Institute Australia; The University of Sydney and Westmead Institute for Cancer Research, Sydney, Australia · Pubmed 24821886
  • Melanoma Institute Australia, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 26072686
2014
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · School of Mathematics and Statistics and Prince of Wales Clinical School, University of New South Wales, Kensington, NSW, 2052, Australia. · Discipline of Infectious Diseases and Immunology Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia. · Discipline of Dermatology, Bosch Institute, Faculty of Medicine, Sydney Medical School, Sydney, NSW, 2006, Australia. · Melanoma Institute Australia, North Sydney, NSW, 2060, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Westmead Institute of Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, 2145, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Pubmed 24435119
  • 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA. · 1] Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Westmead Institute for Cancer Research, NSW, Sydney, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Mater Hospital, Sydney, NSW, Australia [4] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA [3] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [4] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24434899
  • Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven (KU Leuven), Leuven, Belgium. · Surgical Oncology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Dermatology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium. · Embryo and Stem Cells, Department of Development and Regeneration, University of Leuven (KU Leuven), Leuven, Belgium. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Discipline of Surgery, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia. · Pubmed 24390218
  • 1] Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, University of Massachusetts Medical Center, Worcester, MA, USA. · Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Royal Prince Alfred Hospital, Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, Australia. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Divison of Endocrinology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 24390216
  • School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia. · Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Taiyuan, China. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24121273
  • Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Institut de Cancerologie Gustav Roussy, Villejuif, Paris-Sud, France. Electronic address: · Pubmed 24074765
  • Department of Dermatology, University of Duisburg-Essen, Essen, Germany. · Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · 1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23887304
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Immunology and Oncology Unit, University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 23455323
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
  • Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Missenden Road, Sydney, NSW 2050, Australia. · Pubmed 24366302
2012
  • Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; The Melanoma Institute Australia, New South Wales, Australia. Electronic address: · Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia. · Department of Dermatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy. · Department of Pathology, University of Modena and Reggio Emilia, Reggio Emilia, Italy. · The Melanoma Institute Australia, New South Wales, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, Australia. · Department of Dermatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy; Department of Dermatology, University of Modena and Reggio Emilia, Reggio Emilia, Italy. · Pubmed 22718115
2011
2010
2015
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 25990968
  • Westmead Millennium Institute, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25490969
  • Melanoma Institute Australia, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25477049
  • Melanoma Institute Australia (formerly the Sydney Melanoma Unit), North Sydney, NSW, Australia. · Pubmed 25384702
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 25256128
  • *Melanoma Institute Australia North Sydney †Sydney Medical School The University of Sydney ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital Sydney, NSW, Australia. · Pubmed 25871468
2014
  • Affiliations of authors: Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany (KGG, DS); Royal Prince Alfred Hospital, Camperdown, NSW, Australia (RAS); University of Sydney, Camperdown, NSW, Australia (RAS, JFT); Melanoma Institute Australia, North Sydney, NSW, Australia (RAS, JFT); Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA (KTF); Department of Pathology, and Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY (RM). · Pubmed 24511108
  • Melanoma Institute Australia, Poche Centre, 40 Rocklands Road, North Sydney, NSW, 2060, Australia; Genesis Cancer Care, Mater Sydney Radiation Oncology Centre, Mater Hospital, 25 Rocklands Road, North Sydney, NSW, 2060, Australia. · Pubmed 24032599
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 24802907
  • Melanoma Institute Australia, Sydney, New South Wales 2060, Australia; · Pubmed 24489105
  • *Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands †Melanoma Institute Australia, Sydney, New South Wales, Australia Disciplines of ‡Surgery, and §Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; and ¶Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25072430
  • Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California (D.M.M., J.L.H., D.S.B.H.); Department of Tissue Oncology and Diagnostic Pathology (R.A.S., M.E.B., J.F.T.) and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia (J.F.T.); Sydney Medical School, The University of Sydney, Sydney, Australia (R.A.S., J.S.W., M.E.B., J.F.T.); Melanoma Institute Australia, Sydney, Australia (R.A.S., J.S.W.); Cellular and Molecular Biology Laboratory, Institute of Histology and Embryology, Mendoza, Argentina (M.R.); Tumor Biology Laboratory, Institute of Medicine and Experimental Biology of Cuyo, Mendoza, Argentina (L.M.V.-R.); Department of Pathology (R.M.), Center for Molecular Oncology (R.M.), and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York (R.M.); Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California (D.L.M.); Brain Tumor Center, Saint John's Health Center, Santa Monica, California (G.B., D.F.K.). · Pubmed 24968695
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 24748128
  • Melanoma Institute Australia, Poche Centre, 40 Rocklands Road, North Sydney, NSW, 2060, Australia; Department of Sydney Melanoma Diagnostic Centre, Missenden Road Camperdown, NSW, 2050, Australia; Discipline of Dermatology, The University of Sydney, Sydney, NSW, Australia. · Pubmed 24641247
  • *Melanoma Institute Australia †Sydney Medical School, The University of Sydney, Sydney ‡Nuclear Medicine and Diagnostic Ultrasound, RPAH Medical Centre, Newtown, New South Wales, Australia. · Pubmed 24633018
  • *Department of Dermatology †Robert H. Lurie Cancer Center †††Department of Preventive Medicine and the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL ‡Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY §Department of Pathology and Laboratory Medicine, Dermatopathology, UCLA Medical Center, Los Angeles ‡‡Departments of Pathology and Dermatology, University of California, San Francisco, San Francisco, CA ¶Pathology Service, Massachusetts General Hospital, Boston, MA #Department of Pathology, University of Pennsylvania, Philadelphia ¶¶Rabkin Dermatopathology Laboratory, P.C., Tarentum, PA Departments of **Pathology ††Dermatology, University of Michigan Medical Center, Ann Arbor, MI §§Department of Pathology, Section of Dermatopathology ∥∥Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX ∥Department of Histopathology, Royal Surrey County Hospital & Division of Clinical Medicine, University of Surrey, Guildford, Surrey, UK ##Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Melanoma Institute Australia and The University of Sydney, NSW, Australia ***Departments of Dermatology, Chonnam National University Medical School, Gwangju, Korea. · Pubmed 24618612
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
2013
  • *Melanoma Institute Australia Disciplines of †Pathology **Surgery, Sydney Medical School, The University of Sydney Departments of ‡Tissue Pathology and Diagnostic Oncology ††Melanoma and Surgical Oncology, Royal Prince Alfred Hospital §Royal College of Pathologists of Australasia, Sydney, NSW ¶¶Royal Adelaide Hospital and Flinders University, Adelaide, SA, Australia ∥Department of Pathology, Ninewells Hospital and Medical School, Dundee, Scotland ¶Cedars-Sinai Medical Center, Los Angeles, CA #Departments of Pathology and Dermatology, University of Texas-MD Anderson Cancer Center, Houston, TX ‡‡Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB ∥∥Department of Pathology, Capital District Health Authority and Dalhousie University, Halifax, NS, Canada §§Royal Victoria Hospital, Belfast, UK. · Pubmed 24061524
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23298266
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Pubmed 23851608
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23557327
  • Melanoma Institute Australia, The University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia. · Pubmed 23553208
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23426339
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23403819
  • Melanoma Institute Australia and Westmead Hospital, 40 Rocklands Rd, North Sydney, NSW 2060, Australia. · Pubmed 23026937
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Melanoma Institute Australia, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 22290565
  • Melanoma Institute Australia, Australia. · Pubmed 22962325
  • Surgery (Melanoma and Surgical Oncology), University of Sydney, Melanoma Institute Australia and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, New South Wales. · Pubmed 22762064
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 22736239
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney NSW 2060, Australia. · Pubmed 22711850
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 22156613
2011
  • Melanoma Institute Australia, Sydney, Australia. · Pubmed 21913021
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia. · Pubmed 21343559
2010
  • Sydney Melanoma Unit and Melanoma Institute Australia, Royal Prince Alfred and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 19672660
  • Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 20626102
  • Melanoma Institute Australia (formerly Sydney Melanoma Unit), Sydney, NSW, Australia. · Pubmed 20490699
2009
  • Royal Prince Alfred Hospital Discipline of Pathology, The University of Sydney, Camperdown Melanoma Institute Australia, New South Wales, Australia. · Pubmed 19851128
  • Melanoma Institute Australia, North Sydney, NSW 2060, Australia. · Pubmed 19647595
  • Melanoma Institute Australia and Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia · Pubmed 19786669
  • Discipline of Pathology, The University of Sydney, Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital and Melanoma Institute Australia. · Pubmed 19666944
  • Melanoma Institute Australia incorporating the Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia. · Pubmed 19472395
  • Melanoma Institute Australia, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 19262412
Miscellaneous institutions in Sydney
2016
  • Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Duisburg-Essen, Germany. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Duisburg-Essen, Germany. · Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Duisburg-Essen, Germany. · Institute of Human Genetics, Medical University of Graz, Graz, Austria. · Tissue Pathology and Diagnostic Oncology, Camperdown, NSW, Australia. · The University of Sydney, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, Catholic University, Rome, Italy. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Duisburg-Essen, Germany. · Pubmed 26744134
2008
  • The Sydney Melanoma Unit, North Sydney, New South Wales, Australia. · Pubmed 18781136
2007
  • Department of Anatomical Pathology, Sydney Cancer Centre, Australia. · Pubmed 17276948
Westmead Hospital
2014
  • Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Melanoma Institute of Australia and Westmead Hospital, Sydney, Australia. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pediatrics, University of Cincinnati, Cincinatti, Ohio. · Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Astra Zeneca, Macclesfield, United Kingdom. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Pubmed 25297634
2015
  • 1Melanoma Institute Australia, North Sydney, NSW 2Sydney Medical School, The University of Sydney, Camperdown, NSW 3Immunogenomics Laboratory, Australian National University, Canberra, ACT 4Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Qld 5Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW 6Bioplatforms Australia, Macquarie University, North Ryde, NSW 7Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic 8The Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Vic 9Departments of Melanoma and Surgical Oncology 10Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; these authors contributed equally. · Pubmed 26517638
  • Westmead Millennium Institute, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25490969
  • aDepartment of Dermatology, Westmead Hospital, Westmead bSydney Medical School, The University of Sydney cDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital dMelanoma Institute Australia eDepartment of Tissue Pathology and Diagnostic Oncology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, New South Wales, Sydney, Australia. · Pubmed 25380183
2014
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
2013
  • Sydney Medical School, The University of Sydney at Westmead Millennium Institute for Medical Research, Sydney, NSW, Australia. · Pubmed 23738911
  • University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 23190890
  • Melanoma Institute Australia and Westmead Hospital, 40 Rocklands Rd, North Sydney, NSW 2060, Australia. · Pubmed 23026937
  • The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Pubmed 22931913
2012
  • Sydney Medical School, The University of Sydney at Westmead Millennium Institute, Sydney, New South Wales, Australia. · Pubmed 21956122
  • Department of Dermatology, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 22804352
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
2010
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 20478260
2009
  • Westmead Institute for Cancer Research, University of Sydney, Westmead Millennium Institute and Westmead Hospital, Australia. · Pubmed 19149898
57 Other Locations Show
Yearly article counts 0192331402527132723179